Herzzentrum - unispital-basel.ch · der Kardiologie des USB hat sich hier zum Beispiel das Konzept der interdisziplinŠren systematischen Mortality und Morbidity (M&M) Konferenz etabliert

HerzzentrumUniversitŠtsspital Basel

Herzzentrum

UniversitŠres HerzzentrumJahresbericht 2018

03

Vorwort

Friedrich Eckstein Christian MŸller Stefan Osswald

Mehr wissen. Alles geben.Mehr machen. Besser kšnnen.Zusammen arbeiten. Mehr erreichen.

02

Liebe Kolleginnen und Kollegen

Die strukturelle und persšnliche Vernetzung der Herzchirurgie, Kardiologie und des Cardiovascular Research Institute Basel (CRIB) zum UniversitŠren Herzzentrum am USB konnte in den letzten Monaten mit grossem Elan vorangetrieben werden. Wir sind sehr dankbar, hierbei auch auf die tatkrŠftige UnterstŸtzung unserer Spitallei-tung und unseres Verwaltungsrates zŠhlen zu kšnnen. Diese Vernetzung stellt die bestmšgliche Behandlung unserer Patienten mit kardiovaskulŠren Erkrankungen sicher Ð jetzt und auch in Zukunft. Als UniversitŠres Herzzentrum des UniversitŠtsspitals Basel stehen wir fŸr Patientenzentriertheit und QualitŠt in Therapie, Innovation und Forschung.

Alle Spitzenleistungen unseres UniversitŠren Herzzentrums sind nur durch die enge Verzahnung mit Ihnen als HausŠrztinnen und HausŠrzten, als niedergelassene Kardiolog(inn)en, und Kolleginnen und Kollegen in unserem interdisziplinŠren und Ÿberregionalen Behandlungsnetzwerk mšglich. Der enge fachliche und persšnliche Austausch mit Ihnen bildet dabei die Basis fŸr die BehandlungskontinuitŠt und den Langzeiterfolg.

Wir mšchten Ihnen daher auch an dieser Stelle fŸr den offenen konstruktiven Dialog und die sehr gute Zusammenarbeit danken.

Inhalt

01 Dienstleistungen 06 - 13

Leistungsstatistik UniversitŠtsspital Kardiologie / Herzchirurgie / PartnerspitŠler Outcomestatistik 02 Kardiologie 14 - 25

Interventionelle Kardiologie Elektrophysiologie Echokardiographie Cardiac Imaging Herzinsuffizienz KardiovaskulŠre PrŠvention / GUCH KARAMBA (Kardiale Rehabilitation) Kurzzeitklinik / Pflege / MTT / MTRA Administration / Controlling Outcome Forschung Swiss-AF Cohort Study Grundlagenforschung 03 Herzchirurgie 26 - 29

04 Notfallzentrum 30 - 31

05 Medizinische Intensivstation 32 - 33

06 KardioanŠsthesie 34 - 35 07 Operative Intensivbehandlung (OIB) 36 - 37

08 Lehre 38 - 39

09 Finanzielles 40 - 43 10 Publikationen Kardiologie / Herzchirurgie 44 - 55

Originalarbeiten / Reviews / Case reports / Editorials

Buchkapitel / Letters to the editor

11 Auszeichnungen 56 - 57

12 Kontakt 58

0504

StationŠre Patienten

Kardiologische Ambulatorien

Schrittmacherkontrollen

ICD-Kontrollen

Rhythmussprechstunde

Kardiologische AbklŠrungen

Herzinsuffizienz-Sprechstunde

LVAD-Kontrollen

GUCH-Sprechstunde

Privatsprechstunden

Hypertonie Sprechstunde

Rauchstopp Sprechstunde

Konsile

Spezialuntersuchungen

Linksherzkatheter

Rechtsherzkatheter

Myokard-Biopsie

Elektrophysiologische Untersuchungen

Echokardiographien, transthorakal

Echokardiographien, transoesophageal

Stressechokardiographien

24 h Blutdruckmessungen

Somnotouch

Herz-MR

Herz-CT

Ergometrien (inkl. Nuklearmedizin)

Spiroergometrien

Myokardperfusionsszintigraphien

Herz-PET

2016

2'200

1'691

1'649

452

1'049

547

45

130

1'304

1'001

758

1'602

2'473

155

27

71

10'810

1'051

220

1'224

296

738

356

2''074

84

1'466

55

Leistungsstatistik Kardiologie UniversitŠtsspital

Dienstleistungen

01 Dienstleistungen

06

2015

2'050

1'644

1'514

398

881

547

n.a.

122

1'008

813

541

1'459

2'525

175

23

80

9'275

979

145

1'004

137

715

232

1'248

72

1'618

n.a.

2017

2'191

1'712

1'582

481

1'463

587

86

140

1'451

1'277

968

2'520

2'481

156

15

82

11'691

1'118

236

1'275

471

994

586

2'301

120

977

685

Elektrokardiographie

Ruhe-EKG 1

Langzeit-EKG Untersuchungen inkl. R-Tests

Therapie

Kardioversionen

Schrittmacherimplantationen

Schrittmacherwechsel / Schrittmacherrevision

Elektrodenentfernungen

ICD-Implantationen

ICD-Wechsel / ICD-Revision

CRT-ICD / CRT-PM

Implantierbare Loop Recorder

Ablationen

PTCA

Mehrast-PTCA

Sinus Coronarius Reduktion

Aortenvalvuloplastien

Verschluss eines ASD / PFO

Nicht operativer Aortenklappenersatz (TAVI)

- davon transfemoral / transsubclavia

- davon transapikal

MitraClip

Direkte Mitralklappenanuloplastie

Direkte Trikuspidalvalanuloplastie

Renale Denervationen

Vorhofsohrverschluss

Mitralklappenvalvuloplastien

ParavalvulŠrer Leckverschluss

TASH

Rehabilitation (KARAMBA)

Leistungsstatistik Kardiologie UniversitŠtsspital

07

2015

11'473

1'842

208

283

77

15

125

47

57

n.a.

646

1'279

422

n.a.

1

27

103

85

18

13

n.a.

n.a.

1

11

5

n.a.

1

389

2016

15'082

1'783

228

304

73

29

88

54

53

50

710

1'278

387

6

1

33

131

112

19

15

n.a.

n.a.

1

9

n.a.

2

n.a.

331

2017

13'786

1'776

245

287

63

17

85

51

55

49

741

1'336

385

3

3

41

131

120

11

12

1

n.a.

4

21

2

1

1

411

2018

2'038

1'675

1'468

454

1'624

544

48

137

1'423

1'639

1'062

2'553

2'489

187

13

57

12'413

1'191

283

1'252

369

1'079

621

1'902

935

885

1'005

2018

14'147

1'801

260

308

58

14

96

62

48

43

681

1'208

405

2

2

37

118

113

5

16

3

1

0

20

2

2

1

422

Service de Cardiologie Hopital du Jura

ErgometrienEchokardiographie, transthorakalEchokardiographie, transoesophagealMRIEKGR-TestSchrittmacherimplantationenElektrodenentfernungen/Repositionierung Loop recorder Implantation Loop recorder KontrolleSchrittmacherkontrollenICD-KontrollenHolter 24 h Blutdruckmessungen

Leistungsstatistik PartnerspitŠler

Dienstleistungen

01 Dienstleistungen

2015

136537

484

424123117

n.a.n.a.374

36n.a.n.a.

2016

n.a.378

829

27254

11n.a.n.a.171

9139n.a.

2017

2624

3054

3522

2810

12

17719

1945

Leistungsstatistik Herzchirurgie UniversitŠtsspital

Prozeduren

Operationen mit Herz-Lungen-Maschine (HLM)

Operationen ohne Herz-Lungen-Maschine (HLM)

Sonstige Operationen (Schrittmacher, ICD, Perikard, etc.)

Kombinationseingriffe (Herzoperationen mit HLM)

Bypasschirurgie

Aortokoronarer Bypass (AKB) isoliert mit HLM

Aortokoronarer Bypass (AKB) ohne HLM ("OPCAB")

Kombinationseingriffe (AKB+)

Aortenklappenchirurgie

Aortenklappenersatz biologisch

Aortenklappenersatz mechanisch

Aortenklappenrekonstruktion mit Eigenperikard (OP nach Ozaki)

Aortenklappen- und Wurzelersatz ("Composite")

Aortenklappenrekonstruktion

Transapikaler Aortenklappenersatz (ohne HLM, mit Kardiol.)

Mitralklappenchirurgie

Mitralklappenersatz mit HLM

Mitralklappenrekonstruktion mit HLM

Rekonstruktionsrate (geplant vs. durchgefŸhrt)

Andere

Trikuspidal- und Pulmonalklappenchirurgie

Trikuspidalklappenrekonstruktion

Pulmonalklappenersatz

09

2015

1'031

568

101

195

195

345

208

29

110

208

119

34

8

23

25

18

133

43(40/3)

87

(43/44)

97%

3

16

16

2016

1'098

533

121

196

198

313

168

27

116

234

127

35

15

13

24

19

121

46 (43/3)

73 (33/40)

98%

2

12

11

1

2017

1'061

535

99

233

229

319

165

20

134

225

107

28

10

30

29

16

121

32 (26/6)

85 (42/43)

97%

4

26

24

2

2018

8707

2159

3153

22916

15562

2269

2018

1'035

596

42

175

195

337

203

20

114

213

131

18

5

27

23

9

141

25 (23/2)

111 (51/60)

96%

5

23

20

1

08

Operationen an der thorakalen Aorta

Sonstige Eingriffe

Vorhofablation/Pulmonalvenenisolation

Vorhofseptumdefekt

Extrakorporale Zirkulation (EKZ)

Minimalisierte EKZ ("MECC")

Hypothermer Kreislaufstillstand

Kardiale UnterstŸtzungssysteme

Intraaortale Ballonpulsation (IABP)

Extrakorporale Membranoxygenation (ECMO)

LVAD (Destinationstherapie)

Eingriffsdringlichkeit

Elektiv

Notfall

Dringlich

Konsile Kardiologie

2016

82

48

10

38

533

146

74

49

28

21

3

567

154

129

285

Leistungsstatistik Herzchirurgie UniversitŠtsspital

Dienstleistungen

01 Dienstleistungen

2015

87

50

16

34

568

196

71

61

42

19

2

504

135

141

269

2017

105

51

15

36

535

145

90

51

21

22

8

577

122

77

308

2018

99

55

20

35

596

184

74

48

10

34

4

585

160

68

597

10 11

Outcome Statistik

Kontrollmechanismen, welche auf kontinuierlicher und umfassender Basis die QualitŠt der angebotenen medizinischen Leis-tungen erfassen und quantifizieren, nehmen in unserem Spitalalltag eine wichtige Rolle ein. Dies erlaubt nicht nur, die QualitŠt der erbrachten Leistung zu messen und zu rapportieren, sondern dient auch dazu, negative oder positive Signale frŸh zu erfassen, um gegebenenfalls Anpassungen prompt vornehmen zu kšnnen. Als wichtiger Baustein der QualitŠtskontrolle in der Kardiologie des USB hat sich hier zum Beispiel das Konzept der interdisziplinŠren systematischen Mortality und Morbidity (M&M) Konferenz etabliert. Im Rahmen regelmŠssiger M&M-Konferenzen werden alle Patienten mit besonders schweren KrankheitsverlŠufen besprochen.

In der untenstehenden Tabelle sind alle TodesfŠlle aufgelistet, die nach einer kardiologischen Intervention aufgetreten sind. Hierzu ist anzumerken, dass dabei auch TodesfŠlle rapportiert werden, welche nicht kausal mit der Intervention zusammenhŠngen. Deshalb wird zusŠtzlich auch die procedure-related Mortality rapportiert.

In-hospital Tod

N (%)

37 (3.1%)

27 (2.1%)

8 (5.6%)

0

4 (1.1%)

0

1 (2.1%)

0

0

0

1 (1.8%)

Untersuchungstyp

PTCA / Stentimplantationen

Linksherzkatheter (ohne PTCA)

Interventionelle Klappeneingriffe *

Katheterablationen

Schrittmacher-Implantationen

Schrittmacher-Wechsel/-revision

ICD-Implantationen

ICD-Wechsel/-revision

CRT-ICD / CRT-PM

Elektrodenextraktion

Rechtsherzkatheter

Biopsie

ASD/PFO/LAA VerschlŸsse

* TAVI (n=118, davon 113 transfemoral/transsubclavia), Valvuloplastien der Aortenklappe oder Mitralklappe (AVP: n=2, MVP: n=2), Mitraclip (n=16), indirekte Mitralklappenannuloplastie (n=0), direkte Mitralklappenannuloplastie (n=3), Verschluss paravalvulŠres Leck (n=2)

12

Dienstleistungen

01 Dienstleistungen

13

Anzahl

Untersuchungen

1'208

1'281

143

681

366

158

48

14

187

13

57

Procedure-related Tod

N (%)

3 (0.2%)

1 (0.1%)

3 (2.1%)

0

0

0

0

0

0

0

0

Interventionelle Kardiologie

Team

�rztliches Team

Prof. Christoph KaiserProf. Raban JegerDr. Gregor FahrniDr. Raphael Twerenbold

Wissenschaftliches Team

Dr. Nicole GilgenMargarete BaumgartnerAndrea Harder-AllgšwerFranziska Jordan

02 Kardiologie

14

Elektrophysiologie

Team

�rztliches Team

Prof. Christian SticherlingProf. Stefan OsswaldProf. Michael KŸhneProf. Tobias Reichlin (bis 30.4.2018)Prof. Beat SchŠrDr. Antonio Madaffari (seit 1.5.2018)Dr. Ivan Zelkovic (Gastarzt bis 30.6.2018)

Technisches Team

Dr. Sven KnechtFlorian Spiess

Team Schrittmacher/ICD Sprechstunde

Christine HuldiAndrea Mussler

Wissenschaftliches Team

Sarah GiesebartGian Všllmin

15

Echokardiographie

Team

�rztliche Mitarbeiter Echokardiographie

Prof. Beat KaufmannProf. Michael ZellwegerProf. Otmar PfisterPD Dr. Daniel ToblerDr. Thilo BurkardDr. Marc Fischer Dr. Philipp HaafDr. Arnheid KesselDr. Wanda LaknerDr. Jens LohrmannProf. Christine Meyer-ZŸrnDr. Karsten MurrayDr. Frank-Peter Stephan

Mitarbeiter Cardiovascular Molecular Imaging

Prof. Beat KaufmannDr. Amanda Ochoa-EspinosaDr. Mukesh PunjabiDr. Lifen XuDr. David Steinl Alexandra Kosareva

02 Kardiologie

16

Cardiac Imaging

Team

Prof. Michael ZellwegerDr. Thilo BurkardDr. Philip HaafKollaboration mit Radiologie und Nuklearmedizin

1717

Herzinsuffizienz

02 Kardiologie

18

Dr. Ina FerelBrigitte FitzeRomy MayrStephanie DšrflingerKristin ShresthaClaudia Stelzig

Team

�rztliches Team

Prof. Otmar PfisterProf. Christian MŸllerProf. Martin GrapowProf. Peter RickenbacherProf. Michael ZellwegerPD Dr. Thilo BurkardPD Dr. Gabriela Kuster PfisterDr. Wanda LaknerDr. Jens LohrmannDr. Jana Steude

VAD-Koordination

Anne MorgenSimon Scheifele

Herzinsuffizienzberatung / Studien

Lukas Weibel (ANP)Salom� RŸmmlerDr. Beate HartmannDr. Dayana FloresDr. Samyut ShresthaJonas Schwarz

19

KardiovaskulŠre PrŠvention / GUCH

Team KardiovaskulŠre PrŠvention / Hypertonie � Standort USB-MedPol

Dr. Thilo BurkardDr. Andrea MeienbergDr. Delphine GlinzDr. Corinna KlŸberDr. Thenral SocratesDr. Annina Vischer

Dr. Maria-Luisa de Perna, AA (bis 30.6.18)Dr. Daniela Zwisler (bis 30.6.18)Dr. Fabio Stallone (bis 30.9.18)Dr. Yu-Ching Liu (bis 31.12.18)

Dr. Roman VšgelinDr. Amely Heinzelmann

Team GUCH / Angeborene Herzfehler

PD Dr. Daniel ToblerDr. Ketina ArslaniDr. Cornelia GanzoniSimon Frey

Rauchstopp-Beraterinnen:Silvia CaviolaUta EnglerNathalie Klaus

Prof. Birgit DonnerNico RofflerGaby Frey

KARAMBA (Kardiale Rehabilitation)

02 Kardiologie

Team

�rzte

Prof. Otmar PfisterDr. Thilo BurkardDr. Ketina ArslaniDr. Olivier ClercDr. Marc FischerDr. Sebastian ImhofDr. Rupprecht LangeDr. Karsten MurrayDr. Fabio Stallone

Pflege/Administration

Antonia CandelaGaby Frey

Sporttherapie

Madeleine Wick (Leitung)Andrea Iris BannwartLivia GrafJulia LŠderachAdrian NŠf

Ruth OstertagStephanie RuchFabienne Schneider

Physiotherapie

Yolanda Sanchez (Leitung)Natali MarjanovicPatrick ProbstKevin Vogel

Aquagymnastik

Monika RšthlisbergerTanja Biedermann

Herzinsuffizienzberatung

Lukas Weibel (ANP)Salom� RŸmmler

Kurzzeitklinik/Pflege/MTRA

21

Team KUK (Station 8.2)

Susanne Timus (Leitung)Catherine MalgatDiana CascaisMartina SabatinoProf. Christian MŸllerDr. Wanda LaknerDr. Jens Lohrmann

Team Pflege / MTT

Rosemarie BŸhrer (Leitung)Dr. Sven Knecht Bettina Andris Paul BlindAnnette Bus (bis 12.18) Stephan GriessbachAntje Henke Christiene Huldi Egzona Fazlija (ab 08.18) Evelyn Flandšrffer (ab 03.18)Claudia KernbachAndreas Klass (ab 05.18) Iris Klostermann (bis 05.18)Nicole KunstHeidi Linder Sšren LorenzClaudia LutzNadine Mansueto Daniele MinioAndrea MusslerGabriela Rigotti Brigitta SorgKristina Valaityte Tatjana Weber (ab 01.18)Alice Wingerdt Ayse Ulu

Team MTRA

Selina Botta Lea Burri Alena ChristenSeverine Dziergwa Natalie Geiser Franziska Giger Barbara Imfeld Aurore Jordan Kathrin Kuhn Isabella Leuenberger Alexandra Matter Matthias Merz Manuel Reidy Nadine Ruettener Christine Orsingher Gina Wietschorke

20

Administration / Controlling

Team

Arton JusajRocio AlvarezBilal BektasMelanie JostSarah RiglingAleksandra SchweizerChristina HeyerGaby SchwobUrsula VogtHrvoje VukovicNoelia Puglisi (Lernende)

02 Kardiologie

22 21

Outcome Forschung

Team

Prof. Christian MŸllerProf. Danielle Menosi GualandroPD Dr. Tobias BreidthardtDr. Ayman AlhussiniMelissa Lee Fen AmreinMahnoor AnwarBenjamin BaumgartnerDr. Jasper BoeddinghausLukas CrotonSebastian DietscheStephanie DšrflingerDr. Jeanne du Fay de LavallazPaul DuweDr. Ina FerelBrigitte FitzeDr. Dayana Flores GonzalesMichael FreeseMarc GeigerDominic GermanierRaoul GigerBettina GlatzJohanna GŸckel

02 Kardiologie / Klinische Forschung

Benjamin HafnerDr. Beate HartmannNatascha HerrReka HidvegiUrsina HoneggerClaudia HuckRahel IsenrichLydia JorayElif KeserDerya KilincIrina KlimmeckDr. Luca KoechlinDr. Nikola KozuharovChristine KruseCaroline KulungaraDr. Wanda LaknerSabrina LauleDr. Jens LohrmannStella MarbotJasmin MartinRomy MayrMario MeierKathrin MeissnerFabiola Metry

Eleni MichouDr. Thomas NestelbergerDr. Christian PuelacherMax RiegerMarkus RiestererTherese RinderknechtLorraine SazgaryCarmela SchumacherTobias SchwarzKristin ShresthaClaudia StelzigThomas StollDr. Ivo StrebelDevran TopyŸrekDr. Raphael TwerenboldValentina TršsterRonja VogtJanine VšgeleJonas Elias WalterMalgorzata WegnerDesiree WusslerCarine Xavier CoelhoTibor ZehntnerDr. Tobias Zimmermann

23

24

Swiss-AF Cohort Study

Team

Swiss-AF Cohort Study

Prof. Stefan OsswaldProf. Michael KŸhneProf. Christian SticherlingProf. Christine Meyer-ZŸrnProf. David Conen Dr. Stefanie AeschbacherDr. Steffen BlumDr. Philipp KrisaiDr. Christiane PudenzDr. Javier Ruperti RepiladoDr. Anne SpringerSebastian BergerLorin FršhlichTobias Gšldi Peter HŠmmerlePascal Meyre

Michel Mongiat

Philipp Reddiess

02 Kardiologie / Klinische Forschung

Andreas ReusserAleksandra SchweizerSamuel StempfelGian Všllmin Von der CTU

Dr. Michael CoslovskyPascal BenkertPatrick Simon

23

Cardio Biology Team

Prof. Marijke BrinkGian R. BrouwerPhilippe HeimChristian MorandiHagena ThuraisingamDr. Lifen XuMatthias Zumbach

Myocardial Research Team

PD Dr. Gabriela Kuster PfisterProf. Otmar PfisterDr. Melania Balzarolo (Post-Doc ab 9.18)Dr. Giacomo Della Verde (Post-Doc bis 9.18)Dr. Lifen XuVera Lorenz, M. Sc. Dr. Michika Mochizuki (Post-Doc bis 8.18)Daria Monogiou Belik (PhD Student), M. Sc.

Molecular Imaging Team

Prof. Beat KaufmannDr. Amanda Ochoa-EspinosaDr. Mukesh PunjabiDr. David Steinl Dr. Lifen XuAlexandra Kosareva, M. Sc.

02 Kardiologie / Grundlagenforschung

25

Klinik fŸr Herzchirurgie

Team

�rzte

Prof. Friedrich Eckstein Prof. Oliver Reuthebuch Prof. Martin Grapow Prof. Dr. Paul Mohacsi (Teilzeit, seit 05.18)PD Dr. Denis BerdajsPD Dr. Urs NiederhŠuser (seit 11.18)Dr. David Santer, PhDDr. UIrich SchurrDr. Florian RŸter

03 Herzchirurgie

Fach- und Rotationsassistenten Herzchirurgie

Vladislav BorisovRaul Ciprian BonchisAlejandro Ramirez CardonaFlorian Meissner Constantin Mork Gregory James ReidThibault SchaefferDr. Jasmin Hasmik Shahinian

Rotationsassistenten Kardiologie

Dr. Fabio StalloneDr. Thomas Nestelberger

Rotationsassistenten Innere Medizin

Reto Thoma Julia Geenen

26 27

28

Klinik fŸr Herzchirurgie

Team

Physician Assistants

Waldemar Gerr

Kardiotechniker

Thomas DšbeleClaudia Endres (bis 11.18)Selin KoracBejtush RrhamaniSimon Scheifele (in Ausbildung)Urs Zenklusen

Forschungsgruppenteam

PD Dr. Anna MarsanoVladislav Borisov, MD (bis 08.18)Francesca Carminati, BSc (08.18)Deborah Fusco, BSc (12.18)Giuseppe Isu, PhDAlessia Pisanu, BSc (bis 05.18)Gregory Reid, MDDiana Robles DiazLaia Gili Sole, MScEmanuela Vitale, MSc (03.18)

03 Herzchirurgie

Chirurgische Station 4.1

Marcel HentzTatjana Dettmer (seit 05.18)Fr�d�rique Foell (bis 05.18)Karin StiegerAlice Stšlke

Chirurgische Station 7.1

Jessica Borer (seit 06.18)Anne Straube (seit 05.18)Sibylle Waldmann

Sekretariat

Jolanda GiessMiriam BoughalmiBiljana MartiBrigitta Gahl, PhDJanine Všgele

2729

30

Notfallzentrum

Team

�rzte Kader

Prof. Roland BingisserPD Dr. Christian NickelDr. Christian Beca Dr. Christoph BeckerDr. Luc BlattmannDr. Nicolas Bless Dr. Britta BussDr. Michelle BrŠutigam Dr. Sonja CronenbergDr. Peter Diel Dr. Vera Freund Dr. Maria GšttlDr. Gerhard JŠckhDr. Gilbert KrŠhenbŸhl Dr. Kriemhild LippayDr. Gregory MansellaDr. Sebastian MŸller Dr. Caroline Polzer Dr. Elisabth RatzenbšckDr. Christiane Rosin

04 Notfallzentrum

Dr. Jochen RŸdiger Dr. Jana Steude Dr. Irena Straub Dr. Birgit Werner

Pflege Kader

Debbis AllenLilly GavricFranziska ImmbodenKai LŸbenKatharina Matheis

Administration

Monika Stadler

Contolling

Artur Stickel

31

Medizinische Intensivstation

Team

�rzte

Prof. Stephan Marsch Prof. Patrick Hunziker Dr. Gianmarco Balestra Dr. Andreas Christ Dr. Jorge KasperDr. Heidi LedererDr. Magnus StalderPD Dr. Raoul SutterDr. Kai Tisljar

Pflege

Christian Emsden Sabine Hiller Angelika Lehmann Jos� Lopes Monika Strohmeier Marie-Noelle von AllmenLukas Weibel

Sekretariat

Silvia HabeggerDeborah Minnig

05 Medizinische Intensivstation

32 33

KardioanŠsthesie

Team

�rzte

Dr. Joachim ErbDr. Markus MaurerProf. Dr. Daniel BolligerDr. Corinne D’AnticoDr. Stefan GisinDr. David HeppelDr. Andreas LampartDr. Jonas QuittDr. Tobias Jan Steiner Pflegeteam

Patrick MeierSilvia BšniMichael GregorAlfred HofhanslMareike LehmannIsabelle RoseSara RumpelClaus Schmid

06 KardioanŠsthesie

3534

Operative Intensivbehandlung (OIB)

Team

�rzte

Prof. Hans ParggerProf. Martin SiegemundDr. Nadine CueniDr. Daniel Tuchscherer

Dr. Eva AnnenDr. Anita BoltresPD Dr. Andrea Kopp LugliDr. Andreas LŸdinDr. Benjamin MŸllerDr. Carole RimpauDr. Sarah Salvato

07 Operative Intensivbehandlung (OIB)

36

Pflege

Michael WehrliMonika de la Vega-ErniUrsula Barandun SchŠferConrad Wesch

Sekretariat

Janine Anliker

37

Lehre

08 Lehre

Weiter- und Fortbildungs-VeranstaltungenExterne Weiter- und Fortbildung¥ Regionale Fortbildungskurse (Rheinfelden / Bad Bubendorf)

Interne Weiter- und Fortbildung¥ CCU-Rapport, tŠglich 08.00 Uhr¥ Kardiologie, Montag 08.15 Uhr¥ Herzchirurgie, Montag 07.30-08.00 Uhr¥ Departements Konferenz Chirurgie, Montag 08.10-9.00 Uhr¥ Echokardiographie Fortbildung, Montag 12.30-13.30 Uhr¥ Kardiochirurgisches und -medizinisches Meeting, Montag 17.00 Uhr¥ Curriculum AA, Dienstag 7.45 Uhr¥ Seminar KardiovaskulŠre Grundlagenforschung, 1x Monat, alternierend Mo 09.00-10.00 Uhr, bzw. Di 14.00-15.00 Uhr¥ Herzinsuffizienz Lunch, jeweils jeden dritten Dienstag im Monat 12.30-13.30 Uhr¥ Kardiochirurgisches und -medizinisches Meeting, Mittwoch, 17.00 Uhr¥ Kardio-Lunch, Donnerstag 12.30-13.30 Uhr¥ Journal Club, Freitag 08.15-09.00 Uhr¥ Mortality & Morbidity Conference, 1 x Monat, Freitag 12.30-13.30 Uhr¥ Problemorientierte Fall Tutorate (2. Jahreskurs Medizinische FakultŠt Basel)¥ Arzt-Patienten-Unterricht (4. und 6. Jahreskurs Medizinische FakultŠt Basel)

Selbstorganisierte Kongresse / Symposien der Kardiologie Basel¥ medArt basel 2018, 18.-22. Juni 2018, Basel¥ InteruniversitŠres GUCH-Kolloquium, 13. September 2018

Kongresse / Symposien mit Basler Hauptorganisation¥ Basel Valve Summit 26.04.2018 ¥ GREAT Meeting Venice, 05.-06.07.2018¥ "New Swiss Horizon" Electrophysiology-meeting Lenzerheide, 21.-23.09.2018¥ EKG Kurs fŸr Assistenten, 08./09.11.2018, Luzern¥ EHRA Education Course - Implantable Cardioverter Defibrillator Module, Berlin, 14./15.06.2018¥ 9th Ascona International Workshop on Cardiomyocyte Biology; Congressi Stefano Franscini, Monte Veritˆ, Ascona; 22.-26.04.2018 (Prof. M. Brink)¥ EuroGuch MŸnster, 20.-21.04.2018¥ SwissRhythm 2018, 29.-30.11.2018, Luzern

Einsitz in Standesorganisationen¥ Prof. B. Kaufmann PrŠsident Arbeitsgruppe Echokardiographie und kardiovaskulŠre Bildgebung Mitglied Board Arbeitsgruppe kardiovaskulŠre Biologie Mitglied Finanzkommission SGK¥ Dr. T. Burkard: Revisor Schweizerische Hypertoniegesellschaft

38

¥ Prof. F. Eckstein: VizeprŠsident im Vorstand der Schweizerischen Gesellschaft fŸr Herz- und Thorakale GefŠsschirurgie¥ Prof. R. Jeger: SGK Working Group Interventional Cardiology, Board Member¥ Prof. M. KŸhne Vorstandsmitglied Arbeitsgruppe Herzschrittmacher und Elektrophysiologie der SGK Ambassador for young electrophysiologists der EHRA (European Heart Rhythm Association)¥ PD Dr. G. Kuster Pfister Cardiolinc Network, Member Board of Directors Co-Leader WP und Mitglied Management Committee Switzerland, COST-Action CA17129 CardioRNA¥ Prof. Ch. MŸller Leiter, Dissertationsauszeichnungskommission der Medizinischen FakultŠt Basel European Society of Cardiology, Heart Failure Association, Board Member European Society of Cardiology, Biomarker Study Group, Member European Society of Cardiology, Acute Cardiovascular Care Association, Acute Heart Failure Study Group, chair European Society of Cardiology, Heart Failure Association, Committee on Diagnosis, chair European Society of Cardiology, Heart Failure Association, Committee on Acute Heart Failure, member GREAT Network, President¥ Prof. O. Pfister: Vorstand Arbeitsgruppe Herzinsuffizienz der Schweizerischen Gesellschaft fŸr Kardiologie¥ Prof. O. Reuthebuch: Beisitzer im Vorstand der Schweizerischen Gesellschaft fŸr Herzchirurgie¥ Prof. B. SchŠr: Curriculumskommission der medizinischen FakultŠt Basel¥ Prof. C. Sticherling Mitglied des Scientific Writing Committees der European Heart Rhythm Association (EHRA) Past-PrŠsident der AG Herzschrittmacher und Elektrophysiologie der SGK Mitglied der Tarifkommission der SGK¥ PD Dr. D. Tobler Vorstandsmitglied WATCH (Working group teenager and adults with congenital heart disease) Vorstandsmitglied und PrŠsident herznetz.ch (Dachverband angeborene Herzfehler)¥ Prof. M. Zellweger: PrŠsident der SGK

Ausbildung¥ Prof. M. Brink: Themenblockleiterin: Themenblock Herz Kreislauf, 2. Bachelor Studienjahr Themenblock Co-Leiterin, 1. Master Studienjahr Physiologie-Professorin (Vorlesungen, Praktika, Tutoriate)¥ Prof. M. Grapow: Tutoriat 1. JK, Betreuung von 3 Master Studenten, Betreuung von 1 Doktorandin¥ PD Dr. G. Kuster Pfister: Vorlesungen, 2. MA, Betreuung von 2 Masterstudenten und 2 Doktoranden¥ Prof. C. MŸller: Betreuung von 10 Masterstudenten / Tutoriat 4. JK / Betreuung von 14 Doktoranden¥ Prof. O. Reuthebuch: Betreuung von 2 Master Studenten¥ PD Dr. D. Tobler: Betreuung von 1 Masterstudenten / Bachelor 2. Studienjahr: Kongenitale Vitien (9.1.4.2) Bachelor 3. Studienjahr: Diagnose und Therapie angeborener Herzfehler - von der prŠnatalen Diagnose zur postnatalen Therapie (19.4.1.3) Bachelor 3. Studienjahr: Patienten mit angeborenen Herzerkrankungen - Aspekte bei Jugendlichen und jungen Erwachsenen (19.4.1.5)¥ Prof. Ch. Kaiser, Prof. R. Jeger, Prof. T. Reichlin, Prof. B. SchŠr, PD Dr. C. Kuster Pfister: PrŸfer Staatsexamen¥ Prof. O. Pfister: Vorlesungen 2. und 4. 6. Jahreskurs, Abnahme Staatsexamen¥ Prof. B. SchŠr: Themenblockorganisator¥ Prof. B. SchŠr, Prof. T. Reichlin: Staatsexamen¥ Prof. Ch. Sticherling, Prof. S. Osswald, Prof. B. SchŠr, Prof. M. KŸhne, Prof. T. Reichlin: EKG Kurs¥ Prof. Ch. Sticherling, Prof. S. Osswald, Prof. SchŠr, Prof. M. KŸhne: Vorlesungen

39

Finanzielles

09 Finanzielles

ForschungsbeitrŠge

Schweizer Nationalfonds

¥ SNF Projektfšrderung 310030_169905: Kaufmann B. Non-invasive ultrasound molecular imaging of atherosclerosis: development of a clinically translatable tracers for targeting of vascular cell adhesion molecule Beginn: 01.01.2017 / 3 Jahre¥ SNF Projektfšrderung 33IC30_166855/1: Tobler D. Effect of phosphodiesterase-5 inhibition with tadalafil on systemic right ventricular function - a multi-center, double-blindrandomized, placebo-controlled clinical trial Beginn: 01.01.2017 / 5 Jahre¥ SNF Projektfšrderung 156953: Kuster G./Pfister O. Regulators of cardiac progenitor cells: Focus on cancer drug targets Beginn / Dauer: 01.01.2016 / 3 Jahre¥ SWISS-AF (Longitudinal Studies): 33CS30_177520: Conen D., KŸhne M., Osswald S. Swiss Atrial Fibrillation Cohort Study Beginn: 01.04.2018 / 2 Jahre¥ SNF Projektfšrderung 310030_172989: Marsano A. Engineered patches for cardiac repair Beginn: 01.04.2017 / 4 Jahre¥ SNF Projektfšrderung Nr. 32003B_159495/1: MŸller C. APACE Validation Beginn: 01.01.2016 / 3 Jahre¥ SNF Projektfšrderung 32003B_175604/1: MŸller C. BASEL IX Validation Beginn: 1.10.2017 / 3 Jahre¥ SNF Projektfšrderung Nr. 320030_179362/1: MŸller C. Swiss-PMI Beginn: 1.10.2018 / 2 Jahre¥ SNF Projektfšrderung Nr. 32473B_176178: KŸhne M. Health Consequences of the Burden of Atrial Fibrillation (Swiss-AF-Burden) Beginn: 01.10.2017 / 4 Jahre¥ SNF Projektfšrderung 310030-169996: Brink M "Gender-specific mechanisms of cardiac dysfunction in obesity" Beginn 01.10.2016 / 3 Jahre¥ Horizon 2020 / SNF / ERA.Net Rus Plus: Brink M / G. de Keulenaer "The neuregulin-1 pathway in cardiovascular disease: identification of small molecule ErbB4 agonists and identification of patient populations that could benefit the most" Beginn 01.09.2018 / 3 Jahre

40

EU-Grants

¥ 2013 European Union FP7-Health_2013_Innovation 1 (Project 602299), Sticherling C. EU-CERT-ICD Comparative effectiveness research to assess the use of primary prophylactic implantable cardioverter defibrillators in Europe Beginn: 1.10.2013 - 30.09.2018¥ European Union/Eurostars "E!9799 ALVALE, Anatomical Localization of the origin of Ventricular Arrhythmias from the 12-Lead ECG", Reichlin T Beginn: 01.01.2016 / 3 Jahre¥ European Union/Eurostars: Cebris, MŸller C. Combination of classical and high-frequency ECG with Biomarkers into a RiskScore for Exercise ECG Beginn: 01.10.2017 / 3 Jahre

Schweizerische Herzstiftung

¥ KŸhne M.: Swiss-AF-Burden: Rhythm monitoring using 7-day ECG and implantable loop recorders Beginn: 1.10.2018 / 4 Jahre

Stiftung fŸr kardiovaskulŠre Forschung Basel

¥ Brink M., Burkard T., Conen D., Jeger R., Kaiser C., Kaufmann B., Kuster Pfister G., MŸller C., Pfister O., Reichlin T., Sticherling C., Zellweger M.

ForschungsbeitrŠge UniversitŠt Basel

¥ Mochizuki M.: Stay-on-track Beginn / Dauer: 01.08.2017 / 6 Monate

41

Finanzielles

09 Finanzielles

Andere Quellen / Stiftungen

¥ Goldschmidt-Jacobsen-Stiftung T. Reichlin: Refinement and Integration of Advanced ECG Technologies in Clinical Cardiology Beginn / Dauer: 1.4.2015 / 3 Jahre

¥ Freiwillige Akademische Gesellschaft (FAG) Basel Kuster Pfister G.: Role of fms-like tyrosine kinase 3 in cardiac homeostasis

Andere Quellen / Industrie

¥ Abbott: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.)¥ BASEL VIII (MŸller C.)¥ BASEL-PMI (MŸller C.)¥ Beckman Coulter: (MŸller C.)¥ Biomerieux: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.)¥ BRAHMS: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.) BASEL IX - Basel Syncope Evaluation Study (MŸller C.) BASEL V - Acute dyspnea (MŸller C.)¥ B. Braun Melsungen AG: BASKET-SMALL 2-Studie (Jeger R.)¥ Roche: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.) BASEL V - Acute dyspnea (MŸller C.) GALACTIC (MŸller C.)¥ Siemens: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.)¥ Singulex: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.) BASEL VII - Acute Abdominal Pain (MŸller C.) Biochemical and electrocardiographic signatures to detect exercise-induced myocardial ischemia (MŸller C.) BASEL V, BASEL VIII, BASEL IX (MŸller C.)¥ VFWAWF-Pool RŸckkehrer-Stipendium, (Fahrni G.)

42

Sponsoren und Gšnner

¥ Abbott AG¥ Actelion Schweiz¥ A. Menarini AG¥ AstraZeneca AG¥ Bayer (Schweiz) AG¥ Biosense Webster¥ Biotronik Schweiz AG¥ Boehringer Ingelheim ¥ Boston Scientific¥ B.R.A.H.M.S. GmbH¥ B. Braun Melsungen AG¥ BŸhlmann Laborator AG¥ concile¥ Cordis Johnson & Johnson¥ Daiichi Sankyo (Schweiz) AG¥ 8sens biognostics GmbH¥ Edwards Life Science AG¥ Eli Lilly (Suisse) SA¥ Fšrderverein Kardiologie Basel¥ GlaxoSmithKline AG¥ GrŸnenthal Pharma AG¥ Guidant Europe SA¥ IBSA¥ J.C. General Serv. CVBA¥ Johnson & Johnson

¥ Medtronic (Schweiz) AG¥ mepha¥ Merck Sharp & Dohme¥ Mundipharma Medical Company¥ Novartis AG¥ novo nordisk¥ Nycomed Pharma AG¥ Pfizer AG¥ Robapharm AG¥ Roche¥ Sandoz Pharmaceuticals AG¥ Sanofi Aventis SA¥ Schwabe Pharma AG¥ Sigma-Tau Pharma AG¥ Stentys ¥ Stiftung fŸr kardiovaskulŠre Forschung Basel¥ St. Jude Medical (Schweiz) AG¥ Sorin ¥ Swiss Life AG¥ Takeda Pharma AG¥ Terumo ¥ The Medicines Company¥ Vifor Pharma¥ Viollier AG

43

Publikationen

10 Publikationen

44

Originalarbeiten

1. Aeschbacher S, O'Neal WT, Krisai P, Loehr L, Chen LY, Alonso A, Soliman EZ, Conen D. Relationship between QRS duration and incident atrial fibrillation. Int J Cardiol. 2018. Impact Factor 4.034

2. Akiyama E, Van Aelst LNL, Arrigo M, Lassus J, Mir— ñ, Celutkiene J, Choi DJ, Cohen-Solal A, Ishihara S, Kajimoto K, Laribi S, Maggioni AP, Motiejunaite J, Mueller C, Parenica J, Park JJ, Sato N, Spinar J, Zhang J, Zhang Y, Kimura K, Tamura K, Gayat E, Mebazaa A; GREAT (Global Research on Acute Conditions Team) Network. East Asia may have a better 1-year survival following an acute heart failure episode compared with Europe: results from an international observational cohort. Eur J Heart Fail. 2018. Impact Factor 10.683

3. Ambavane A, Lindahl B, Giannitis E, Roiz J, Mendivil J, Frankenstein L, Body R, Christ M, Bingisser R, Alquezar A, Mueller C; TRAPID-AMI investigators. Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department. PLoS One. 2018. Impact Factor 2.766.

4. Arslani K, Roffler N, Zurek M, Greutmann M, Schwerzmann M, et al. Patterns of Incidence Rates of Cardiac Complications in Patients With Congenital Heart Disease. Can J Cardiol. 2018. Impact Factor 4.524

5. Arslani K, Notz L, Zurek M, Greutmann M, Schwerzmann M, et al. Anticoagulation practices in adults with congenital heart disease and atrial arrhythmias in Switzerland. Congenit Heart Dis. 2018. Impact Factor 1.995

6. Badertscher P, Boeddinghaus J, Nestelberger T, Twerenbold R, Wildi K, Sabti Z, Puelacher C, Rubini Gim�nez M, PfŠffli J, Flores D, du Fay de Lavallaz J, Mir— ñ, Martin-Sanchez FJ, Morawiec B, Lohrmann J, Buser A, Keller DI, Geigy N, Reichlin T, Mueller C. Effect of Acute Coronary Syndrome Probability on Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin. Clin Chem. 2018. Impact Factor 8.636

7. Badertscher P, Boeddinghaus J, Twerenbold R, Nestelberger T, Wildi K, Wussler D, Schwarz J, Puelacher C, Rubini Gim�nez M, Kozhuharov N, du Fay de Lavallaz J, Cerminara SE, Potlukova E, Rentsch K, Mir— ñ, L—pez B, Martin-Sanchez FJ, Morawiec B, Muzyk P, Keller DI, Reich-lin T, Mueller C; APACE Investigators. Direct Comparison of the 0/1h and 0/3h Algorithms for Early Rule-Out of Acute Myocardial Infarction. Circulation. 2018. Impact Factor 18.88

8. Badertscher P, Strebel I, Honegger U, Schaerli N, Mueller D, Puelacher C, Wagener M, AbŠcherli R, Walter J, Sabti Z, Sazgary L, Marbot S, du Fay de Lavallaz J, Twerenbold R, Boeddinghaus J, Nestelberger T, Kozhuharov N, Breidthardt T, Shrestha S, Flores D, Schumacher C, Wild D, Osswald S, Zellweger MJ, Mueller C, Reichlin T. Automatically computed ECG algorithm for the quantification of myocardial scar and the prediction of mortality. Clin Res Cardiol. 2018. Impact Factor 4.455

9. Becher PM, Schrage B, Sinning CR, Schmack B, Fluschnik N, Schwarzl M, Waldeyer C, Lindner D, Seiffert M, Neumann JT, Bernhardt AM, Zeymer U, Thiele H, Reichenspurner H, Blankenberg S, Twerenbold R, Westermann D. Venoarterial Extracorporeal Membrane Oxygenation for Cardiopulmonary Support. Circulation. 2018. Impact Factor 18.88

10. Beri N, Daniels LB, Jaffe A, Mueller C, Anand I, Peacock WF, Hollander JE, DeFilippi C, Schreiber D, McCord J, Limkakeng AT, Wu AHB, Apple FS, Diercks DB, Nagurney JT, Nowak RM, Cannon CM, Clopton P, Neath SX, Christenson RH, Hogan C, Vilke G, Maisel A. Copeptin to rule out myocardial infarction in Blacks versus Caucasians. Eur Heart J Acute Cardiovasc Care. 2018. Impact Factor 2.6

11. Bernasconi R, Aeschbacher S, Blum S, Mongiat M, Girod M, Todd J, Estis J, Nolan N, Renz H, Risch L, Conen D, Risch M. Fibroblast growth factor 23 and renal function among young and healthy individuals. Clin Chem Lab Med. 2018. Impact Factor 3.556

12. Biasco L, Radovanovic D, Moccetti M, Rickli H, Roffi M, Eberli F, Jeger R, Moccetti T, Erne P, Pedrazzini G. New-onset or Pre-existing Atrial Fib-rillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis. Rev Esp Cardiol (Engl Ed). 2018. Impact Factor 5.166

13. Boeddinghaus J, Nestelberger T, Twerenbold R, Neumann JT, Lindahl B, Giannitsis E, S¿rensen NA, Badertscher P, Jann JE, Wussler D, Puelacher C, Rubini Gim�nez M, Wildi K, Strebel I, Du Fay de Lavallaz J, Selman F, Sabti Z, Kozhuharov N, Potlukova E, Rentsch K, Mir— ñ, Martin-Sanchez FJ, Morawiec B, Parenica J, Lohrmann J, Kloos W, Buser A, Geigy N, Keller DI, Osswald S, Reichlin T, Westermann D, Blan-kenberg S, Mueller C; APACE, BACC, and TRAPID-AMI Investigators. Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction. Eur Heart J. 2018. Impact Factor 23.425

14. Boeddinghaus J, Twerenbold R, Nestelberger T, Badertscher P, Wildi K, Puelacher C, du Fay de Lavallaz J, Keser E, Rubini Gim�nez M, Wussler D, Kozhuharov N, Rentsch K, Mir— ñ, Martin-Sanchez FJ, Morawiec B, Stefanelli S, Geigy N, Keller DI, Reichlin T, Mueller C; APACE Investigators. Clinical Validation of a Novel High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction. Clin Chem. 2018. Impact Factor 8.636

15. Brasier N, Engelter S, Kolbitsch T, Tabord A, Knobeloch J, KŸhne M, Conen D, Traenka C, Kreutzberger T, Všllmin G, Eckstein J. The quest for indicators of paroxysmal atrial fibrillation in sinus rhythm - the DETECT AF trial. Acta Cardiol. 2018. Impact Factor 0.876

16. Breidthardt T, Brunner-Schaub N, Balmelli C, Insenser JJS, Burri-Winkler K, Geigy N, Mundorff L, Exadaktylos A, Scholz J, Haaf P, Hamel C, Frey D, Delport K, Peacock WF, Freese M, DiSomma S, Todd J, Rentsch K, Bingisser R, Mueller C; BASEL VII Investigators. Inflammatory Biomarkers and Clinical Judgment in the Emergency Diagnosis of Urgent Abdominal Pain. Clin Chem. 2018. Impact Factor 8.636

17. Breidthardt T, Jaeger C, Christ A, Klima T, Mosimann T, Twerenbold R, Boeddinghaus J, Nestelberger T, Badertscher P, Struck J, Bergmann A, Hartmann O, Kalbermatter S, Marenzi G, Mueller C. Proenkephalin for the early detection of acute kidney injury in hospitalized patients with chronic kidney disease. Eur J Clin Invest. 2018. Impact Factor 3.086

18. Breidthardt T, Moreno-Weidmann Z, Uthoff H, Sabti Z, Aeppli S, Puelacher C, Stallone F, Twerenbold R, Wildi K, Kozhuharov N, Wussler D, Flores D, Shrestha S, Badertscher P, Boeddinghaus J, Nestelberger T, Gimenez MR, Staub D, Aschwanden M, Lohrmann J, Pfister O, Osswald S, Mueller C. How accurate is clinical assessment of neck veins in the estimation of central venous pressure in acute heart failure? Insights from a prospective study. Eur J Heart Fail. 2018. Impact Factor 10.683

19. Burkard T, Trendelenburg M, Daikeler T, Hess C, Bremerich J, Haaf P, Buser P, Zellweger MJ. The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography. PLoS One. 2018. Impact Factor 2.766

20. Chandrasekhar J, Baber U, Sartori S, Stefanini GG, Sarin M, Vogel B, Farhan S, Camenzind E, Leon MB, Stone GW, Serruys PW, Wijns W, Steg PG, Weisz G, Chieffo A, Kastrati A, Windecker S, Morice MC, Smits PC, von Birgelen C, Mikhail GW, Itchhaporia D, Mehta L, Kim HS, Valgimigli M, Jeger RV, Kimura T, Galatius S, Kandzari D, Dangas G, Mehran R. Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention WithNew-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Rando-mized Trials From the WIN-DES Initiative. JACC Cardiovasc Interv. 2018. Impact Factor 9.881

21. Conen D, Rodondi N, Mueller A, Beer JH, Ammann P, Moschovitis G, Auricchio A, Hayoz D, Kobza R, Shah D, Novak J, SchlŠpfer J, Di Valentino M, Aeschbacher S, Blum S, Meyre P, Sticherling C, Bonati LH, Ehret G, Moutzouri E, Fischer U, Monsch AU, Stippich C, Wuerfel J, Sinnecker T, Coslovsky M, Schwenkglenks M, KŸhne M, Osswald S for the Swiss AF study investigators. Relationships of Overt and Silent Brain Lesions with Cognitive Function in Patientswith Atrial Fibrillation. J Am Coll Cardiol. 2018. Impact Factor 16.834

22. Cupa J, Strebel I, Badertscher P, AbŠcherli R, Twerenbold R, Schumacher L, Boeddinghaus J, Nestelberger T, Maechler P, Kozhuharov N, Gim�nez MR, Wildi K, du Fay de Lavallaz J, Sabti Z, Sazgary L, Puelacher C, Mueller D, Bianci C, Mir— ñ, Fuenzalida C, Calder—n S, Mart’n-S‡nchez FJ, Iglesias SL, Morawiec B, Kawecki D, Parenica J, Keller DI, Geigy N, Osswald S, Mueller C, Reichlin T. Diagnostic and prognostic value of QRS duration and QTc interval in patients with suspected myocardial infarction. Cardiol J. 2018. Impact Factor 1.339

23. Dan GA, Martinez-Rubio A, Agewall S, Boriani G, Borggrefe M, Gaita F, van Gelder I, Goronek B, Kaski JC, Kjeldsen K, Lip GYH, Merkely B, Okumara K, Piccini JP, Potpara T, Klindt Poulsen B, Saba M, Savelieva I, Tamargo JL, Wolpert C, SticherlingC, Ehrlich JR, Schilling R, Pavlovic N, De Potter T, Lubinski A, Hastrup Svendsen J, Ching K, Sapp JL, Chen-Scarabelli C, Martinez F. Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) working group on Cardiovascular Pharmacology. Europace. 2018. Impact Factor 5.231

24. De Boeck BW, Toma A, Kiencke S, Dehnert C, ZŸgel S, Siebenmann C, Auinger K, Buser PT, Maggiorini M, Kaufmann BA. Altered left ventricular geometry and torsional in high altitude-induced pulmonary hypertension: a 3D echocardiographic study. J Am Soc Echocardiogr. 2018. Impact Factor 6.827

45

Publikationen

10 Publikationen

46

25. De Maria GL, Alkhalil M, Wolfrum M, Fahrni G, Borlotti A, Gaughran L, Dawkins S, Langrish JP, Lucking AJ, Choudhury RP, Porto I, Crea F, Dall'Armellina E Channon KM, Kharbanda RK, Banning AP. Index of Microcirculatory Resistance as a Tool to Characterize Microvascular Obstruction and to Predict Infarct Size Regression in Patients With STEMI Undergoing Primary PCI. JACC Cardiovasc Imaging. 2018. Impact Factor 10.247

26. de Waard GA, Fahrni G, de Wit D, Kitabata H, Williams R, Patel N, Teunissen PF, van de Ven PM, Umman S, Knaapen P, Perera D, Akasaka T, Sezer M, Kharbanda RK, van Royen N; Oxford Acute Myocardial Infarction (OxAMI) Study investigators. Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction. Heart. 2018. Impact Factor 5.42

27. du Fay de Lavallaz J, Badertscher P, Nestelberger T, Flores D, Mir— ñ, Salgado E, Geigy N, Christ M, Cullen L, Than M, Martin-Sanchez FJ, Rodriguez-Adrada E, Di Somma S, Peacock WF, Kawecki D, Boeddinghaus J, Twerenbold R, Puelacher C, Wussler D, Strebel I, Keller DI, Poep-ping I, KŸhne M, Reichlin T, Mueller C; BASEL IX Investigators . Circadian, weekly, seasonal, and temperature-dependent patterns of syncope aetiology in patients at increased risk of cardiac syncope. Europace. 2018. Impact Factor 5.231

28. du Fay de Lavallaz J, Badertscher P, Nestelberger T, Isenrich R, Mir— ñ, Salgado E, Geigy N, Christ M, Cullen L, Than M, Martin-Sanchez FJ, Bustamante Mandri—n J, Di Somma S, Peacock WF, Kawecki D, Boeddinghaus J, Twerenbold R, Puelacher C, Wussler D, Strebel I, Keller DI, Poepping I, Kühne M, Mueller C, Reichlin T; BASEL IX Investigators, Gim�nez MR, Walter J, Kozhuharov N, Shrestha S, Mueller D, Saz-gary L, Morawiec B, Muzyk P, Nowalany-Kozielska E, Freese M, Stelzig C, Meissner K, Kulangara C, Hartmann B, Ferel I, Sabti Z, Greenslade J, Hawkins T, Rentsch K, von Eckardstein A, Buser A, Kloos W, Lohrmann J, Osswald S. Prospective validation of prognostic and diagnostic syncope scores in the emergency department. Int J Cardiol. 2018. Impact Factor 4.034

29. du Fay de Lavallaz J, Puelacher C, Lurati Buse G, Bolliger D, Germanier D, Hidvegi R, Walter JE, Twerenbold R, Strebel I, Badertscher P, Sazgary L, Lampart A, Espinola J, Kindler C, Hammerer-Lercher A, Thambipillai S, Guerke L, Rentsch K, Buser A, Gualandro D, Jakob M, Mueller C; BASEL-PMI Investigators. Daytime variation of perioperative myocardial injury in non-cardiac surgery and effect onoutcome. Heart. 2018. Impact Factor 5.42

30. du Fay de Lavallaz J, Zehntner T, Puelacher C, Walter J, Strebel I, Rentsch K,Boeddinghaus J, Nestelberger T, Twerenbold R, Mueller C. Rhabdomyolysis: A Noncardiac Source of Increased Circulating Concentrations of Cardiac Troponin T? J Am Coll Cardiol. 2018. Impact Factor 16.834

31. Eggimann L, Blum S, Aeschbacher S, Reusser A, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, SchlŠpfer J, Mondet N, KŸhne M, Sticherling C, Osswald S, Conen D. Risk factors for heart failure hospitalizations among patients with atrial fibrillation. PLoS One. 2018.Impact Factor 2.766

32. Egli P, Aeschbacher S, Bossard M, Eggimann L, Blum S, Meyre P, Bargetzi L, Estis J, Todd J, Risch M, Risch L, Conen D. Relationships of kid-ney injury molecule-1 with renal function and cardiovascular risk factors in the general population. Clin Chim Acta. 2018. Impact Factor 2.926

33. Faggioni M, Baber U, Afshar AE, Giustino G, Sartori S, Sorrentino S, Steg PG, Stefanini GG, Windecker S, Leon MB, Stone GW, Wijns W, Serruys PW, Valgimigli M, Camenzind E, Weisz G, Smits PC, Kandzari DE, Galatius S, Von Birgelen C, Jeger RV, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Chieffo A, Dangas GD, Morice MC, Mehran R. Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Patient-Level Pooled Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv. 2018.Impact Factor 9.881

34. Filipovic MG, Aeschbacher S, Reiner MF, Stivala S, Gobbato S, Bonetti N, Risch M, Risch L, Camici GG, Luescher TF, von Schacky C, Conen D, Beer JH. Whole blood omega-3 fatty acid concentrations are inversely associated with blood pressure in young and healthy adults. J Hypertens. 2018. Impact Factor 4.092

35. Garg P, Aziz R, Al Musa T, Ripley DP, Haaf P, Foley JRJ, Swoboda PP, Fent GJ, Dobson LE, Greenwood JP, Plein S. Effects of hyperaemia on left ventricular longitudinal strain in patients with suspected coronary artery disease : A first-pass stress perfusion cardiovascular magnetic resonance imaging study. Neth Heart J. 2018. Impact Factor 1.476

47

36. Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, Bacchi B, Bianchi R, Levinson RA, Wischnewsky M, Seifert B, Schlossbauer SA, Citro R, Bossone E, MŸnzel T, Knorr M, Heiner S, D'Ascenzo F, Franke J, Sarcon A, Napp LC, Jaguszewski M, Noutsias M, Katus HA, Burgdorf C, Schunkert H, Thiele H, Bauersachs J, Tschšpe C, Pieske BM, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Hasenfuß G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Empen K, Felix SB, Delmas C, Lairez O, El-Battrawy I, Akin I, Borggrefe M, Horowitz J, Kozel M, Tousek P, Widimsk� P, Gilyarova E, Shilova A, Gilyarov M, Winchester DE, Ukena C, Bax JJ, Prasad A, Bšhm M, LŸscher TF, Ruschitzka F, Templin C. Long-Term Prognosis of Patients With Takotsubo Syndrome. J Am Coll Cardiol. 2018. Impact Factor 16.834

37. Gilgen N, Farah A, Scheller B, Ohlow MA, Mangner N, Weilenmann D, Wšhrle J, Jamshidi P, Leibundgut G, Mšbius-Winkler S, Zweiker R, Krackhardt F, Butter C, Bruch L, Kaiser C, Hoffmann A, Rickenbacher P, Mueller C, Stephan FP, Coslovsky M, Jeger R; BASKET-SMALL 2 Investigators. Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2. Clin Cardiol. 2018. Impact Factor 2.733

38. Gualandro DM, Puelacher C, LuratiBuse G, Lampart A, Strunz C, Cardozo FA, Yu PC, Jaffe AS, Barac S, Bock L, Badertscher P, du Fay de Lavallaz J, Marbot S, Sazgary L, Bolliger D, Rentsch K, Twerenbold R, Hammerer-Lercher A, Melo ES, Calderaro D, Duarte AJ, de Luccia N, Caramelli B, Mueller C; TropoVasc and BASEL-PMI Investigators. Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery. Am Heart J. 2018. Impact Factor 4.171

39. Gunten SV, Theuns DA, KŸhne M, Reichlin T, Sticherling C, Schaer B. Predictors for early mortality and arrhythmic events in patients with a CRT-D: a two center cohort study. Cardiol J. 2018. Impact Factor 1.339

40. Hern‡ndez-Madrid A, Paul T, Abrams D, Aziz PF, Blom NA, Chen J, Chessa M, Combes N, Dagres N, Diller G, Ernst S, Giamberti A, Hebe J, Janousek J, Kriebel T, Moltedo J, Moreno J, Peinado R, Pison L, Rosenthal E, Skinner JR, Zeppenfeld K; Sticherling C, Kautzner J, Wissner E, Sommer P, Gupta D, Szili-Torok T, Tateno S, Alfaro A, Budts W, Gallego P, Schwerzmann M, Milanesi O, Sarquella-Brugada G, Kornyei L, Sreeram N, Drago F, Dubin A. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace. 2018. Impact Factor 5.231

41. Iglesias JF, Muller O, Zaugg S, Roffi M, Kurz DJ, Vuilliomenet A, Weilenmann D, Kaiser C, Tapponnier M, Heg D, Valgimigli M, Eeckhout E, JŸni P, Windecker S, Pilgrim T. A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary inter-vention: rationale and design of the BIOSTEMI trial. EuroIntervention. 2018. Impact Factor 4.417

42. Jeger R, Reuthebuch O, Fahrni G, Laborde JC, Vogel R, Kaiser C. Supra-annular sizing for transcatheter valve implantation in bicuspid aortic stenosis. Postepy Kardiol Interwencyjnej. 2018. Impact Factor 1.443

43. Jeger R, Farah A, Ohlow MA, Mangner N, Mšbius-Winkler S, Leibundgut G, Weilenmann D, Wšhrle J, Richter S, Schreiber M, Mahfoud F, Linke A, Stephan FP, Mueller C, Rickenbacher P, Coslovsky M, Chandrasekhar N, Osswald S, Kaiser C, Scheller B; BASKET-SMALL 2 Inves-tigators. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet. 2018.Impact Factor 53.254

44. Johannes J, Greutmann M, Tobler D, Bouchardy J, Stambach D, et al. The impact of trisomy 21 on treatment modalities and outcome in adults with congenital heart disease in Switzerland. Pulm Circ. 2019. Impact Factor 2.178

45. Kamber F, Mauermann E, Seeberger E, Guerke L, Mueller C, Bolliger D, Lurati Buse GAL. Peri-operative copeptin concentrations and their as-sociation with myocardial injury after vascular surgery: A prospective observational cohort study. Eur J Anaesthesiol. 2018. Impact Factor 3.958

46. Knecht S, Pradella M, Reichlin T, MŸhl A, Bossard M, Stieltjes B, Conen D, Bremerich J, Osswald S, KŸhne M, Sticherling C. Left atrial ana-tomy, atrial fibrillation burden and P-wave duration - relationships and predictors for single procedure success after pulmonary vein isolation. Europace. 2018. Impact Factor 5.231

Publikationen

10 Publikationen

48

47. Knecht S, Brantner P, Cattin P, Tobler D, KŸhne M, et al. State-of-the-art multimodality approach to assist ablations in complex anatomies-From 3D printing to virtual reality. Pacing Clin Electrophysiol. 2019. Impact Factor 1.441

48. Knecht S, Burch F, Reichlin T, Spies F, MŸhl A, Altmann D, Ammann P, Schaer B, Osswald S, Sticherling C, KŸhne M. First clinical experience of a dedicated irrigated-tip radiofrequency ablation catheter for the ablation of cavotricuspid isthmus-dependent atrial flutter. Clin Res Cardiol 2018. Impact Factor 4.455

49. Koskinas KC, Windecker S, Buhayer A, Gencer B, Pedrazzini G, Mueller C, Cook S, Muller O, Matter CM, RŠber L, Heg D, Mach F; EVOPACS Investigators. Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial. Clin Cardiol. 2018. Impact Factor 2.733

50. Kuck KH, Brugada J, FŸrnkranz A, Chun KRJ, Metzner A, Ouyang F, SchlŸter M, Elvan A, Braegelmann KM, Kueffer FJ, Arentz T, Albenque JP, KŸhne M, Sticherling C, Tondo C; FIRE AND ICE Investigators. Impact of Female Sex on Clinical Outcomes in the FIRE AND ICE Trial of Catheter Ablation for Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2018. Impact Factor 4.712

51. Legrand M, Ludes PO, Massy Z, Rossignol P, Parenica J, Park JJ, Ishihara S, AlHabib KF, Maggioni A, Mir— ñ, Sato N, Cohen-Solal A, Fairman E, Lassus J, Harjola VP, Mueller C, Peacock FW, Choi DJ, Plaisance P, Spinar J, Kosiborod M, Mebazaa A, Gayat E; GREAT (Global Re-search on Acute Conditions Team) Network and INI-CRCT (Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists) network. Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications. Clin Res Cardiol. 2018.Impact Factor 4.455

52. Linde C, Normand C, Bogale N, Auricchio A, Sterlinski M, Marinskis G, Sticherling C, Bulava A, Cano O, Maas A, Witte KK, Rekvava R, Abdelali S, Dickstein K. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the ESC CRT Survey II. Eur J Heart Fail. 2018. Impact Factor 10.683

53. Mangione FM, Biering-S¿rensen T, Nochioka K, Jatene T, Silvestre OM, Hansen KW, S¿rensen R, Jensen JS, Jorgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S. Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the pro-ximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trials. Catheter Cardiovasc Interv. 2018. Impact Factor 2.602

54. McIntyre WF, Conen D, Olshansky B, Halperin JL, Hayek E, Huisman MV, Lip GYH, Lu S, Healey JS. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program. Clin Cardiol. 2018. Impact Factor 2.733

55. Melly L, Cerino G, Frobert A, Cook S, Giraud MN, Carrel T, Tevaearai Stahel HT, Eckstein F, Rondelet B, Marsano A, Banfi A. Myocardial infarc-tion stabilization by cell-based expression of controlled Vascular Endothelial Growth Factor levels. J Cell Mol Med. 2018. Impact Factor 4.302

56. Mir— ñ, Javaloyes P, Gil V, Mart’n-S‡nchez FJ, Jacob J, Herrero P, Marco-Hern‡ndez J, R’os J, Harjola VP, Torres-G‡rate R, Alonso MI, Pi–era P, Mecina AB, Escoda R, MŸller C, Parissis J, Llorens P; ICA-SEMES Research Group researchers. Comparative Analysis of Short-Term Outcomes of Patients With Heart Failure With a Mid-Range Ejection Fraction After Acute Decompensation. Am J Cardiol. 2018. Impact Factor 3.171

57. Mochizuki M, Della Verde G, Soliman H, Pfister O, Kuster GM. Induction of endothelial differentiation in cardiac progenitor cells under low serum conditions. J Vis Exp. Impact Factor 1.184

58. Mueller D, Puelacher C, Honegger U, Walter JE, Badertscher P, Schaerli N, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Hollenstein C, du Fay de Lavallaz J, Jeger R, Kaiser C, Wild D, Rentsch K, Buser A, Zellweger M, Reichlin T, Mueller C. Direct Comparison of Cardiac Troponin T and I Using a Uniform and a Sex-Specific Approach in the Detection of Functionally Relevant Coronary Artery Disease. Clin Chem. 2018. Impact Factor 8.636

59. Mytsyk M, Isu G, Cerino G, Grapow MTR, Eckstein FS, Marsano A. Paracrine potential of adipose stromal vascular fraction cells to recover hypoxia-induced loss of cardiomyocyte function. Biotechnol Bioeng. 2018. Impact Factor 3.952

49

60. Nazerian P, Mueller C, de Matos Soeiro A, Leidel BA, Salvadeo SAT, Giachino F, Vanni S, Grimm K, Oliveira MT Jr, Pivetta EE, Lupia E, Grifoni S, Morello F; ADvISED Investigators. Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D-Dimer for Acute Aortic Syndromes: The ADvISED Prospective Multicenter Study. Circulation. 2018. Impact Factor 18.88

61. NDavarzani N, Sanders-van Wijk S, Maeder MT, Rickenbacher P, Smirnov E, Karel J, Suter T, de Boer RA, Bloch D, Rolny V, Zaugg C, Pfisterer ME, R. Peeters R, Brunner-La Rocca HP for the TIME-CHF Investigators. Novel concept to guide systolic heart failure medication by repeated biomarker testing - results from TIME-CHF in context of predictive, preventive and personalized medicine. EPMA Journal. 2018.Impact Factor 3.900

62. Nebiker CA, Staubli S, SchŠfer J, Bingisser R, Christ-Crain M, Dell-Kuster S, Mueller C, Scamardi K, Viehl CT, Kolleth D, von Holzen U, Oertli D, Rosenthal R. Cortisol Outperforms Novel Cardiovascular, Inflammatory, and Neurohumoral Biomarkers in the Prediction of Outcome in Acute Pancreatitis. Pancreas. 2018. Impact Factor 2.958

63. Occhetta P, Isu G, Lemme M, Conficconi C, Oertle P, RŠz C, Visone R, Cerino G, Plodinec M, Rasponi M, Marsano A. A three-dimensional in vitro dynamic micro-tissue model of cardiac scar formation. Integr Biol (Camb). 2018. Impact Factor 3.294

64. Pilgrim T, Piccolo R, Heg D, Roffi M, TŸller D, Muller O, Moarof I, Siontis GCM, Cook S, Weilenmann D, Kaiser C, Cuculi F, Hunziker L, Eberli FR, JŸni P, Windecker S.Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial. Lancet. 2018. Impact Factor 53.254

65. Puelacher C, Lurati Buse G, Seeberger D, Sazgary L, Marbot S, Lampart A, Espinola J, Kindler C, Hammerer A, Seeberger E, Strebel I, Wildi K, Twerenbold R, du Fay de Lavallaz J, Steiner L, Gurke L, Breidthardt T, Rentsch K, Buser A, Gualandro D, Osswald S, Mueller C; BASEL-PMI Investigators. Perioperative myocardial injury after non-cardiac surgery: incidence, mortality and characterization. Circulation. 2018. Impact Factor 18.88

66. Puelacher C, Wagener M, Honegger U, Assadian M, Schaerli N, Mueller D, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Sabti Z, Sazgary L, Badertscher P, du Fay de Lavallaz J, Marbot S, Kaiser C, Wild D, Zellweger MJ, Reichlin T, Mueller C. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia. Clin Biochem. 2018. Impact Factor 2.434.

67. Reusser A, Blum S, Aeschbacher S, Eggimann L, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, SchlŠpfer J, Manser S, Reichlin T, KŸhne M, Sticherling C, Osswald S, Conen D. QTc interval, cardiovascular events and mortality in patients with atrial fibrillation. Int J Cardiol. 2018. Impact Factor 4.034

68. Rizas KD, Eick C, Doller AJ, Hamm W, von Stuelpnagel L, Zuern CS, Barthel P, Schmidt G, Bauer A. Bedside autonomic risk stratification after myocardial infarction by means of short-term deceleration capacity of heart rate. Europace. 2018. Impact Factor 5.231

69. Roselli C, Chaffin MD, Weng LC, Aeschbacher S et al., Multi-ethnic genome-wide association study for atrial fibrillation, Nat. Genet. 2018.Impact Factor 27.125

70. Rubini Gimenez M, Badertscher P, Twerenbold R, Boeddinghaus J, Nestelberger T, Wussler D, Mir— ñ, Martín-S‡nchez FJ, Reichlin T, Mueller C. Impact of the US Food and Drug Administration-Approved Sex-Specific Cutoff Values for High-Sensitivity Cardiac Troponin T to Diagnose Myocardial Infarction. Circulation. 2018. Impact Factor 18.88

71. Ruperti Repilado FJ, Doerig L, Blum S, Aeschbacher S, Krisai P, Ammann P, Erne P, Moschovitis G, di Valentino M, Shah D, SchlŠpfer J, Stempfel S, KŸhne M, Sticherling C, Osswald S, Conen D. Prevalence and predictors of atrial fibrillation type among individuals with recent onset of atrial fibrillation. Swiss Med Wkly. 2018. Impact Factor 1.928

Publikationen

10 Publikationen

50

72. Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, Pieri M, Skurk C, Lauten A, Landmesser U, Westenfeld R, Horn P, Pauschinger M, Eckner D,Twerenbold R, Nordbeck P, Salinger T, Abel P, Empen K, Busch MC, Felix SB, Sieweke JT, Møller JE, Pareek N, Hill J, MacCarthy P, Bergmann MW, Henriques JPS, Mšbius-Winkler S, Schulze PC, Ouarrak T, Zeymer U, Schneider S, Blankenberg S,Thiele H, SchŠfer A, Westermann D. Impella Support for Acute Myocardial Infarction complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis. Circulation. 2018. Impact Factor 18.88

73. Shahinian JH, Tobler D, Wolff T, Grapow M. Interrupted right-sided aortic arch: performance of umbilical xenograft after primary neonatal corrective surgery. J Thorac Dis. 2018 Impact Factor 2.365

74. Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N Engl J Med. 2018. Impact Factor 79.258

75. Soeiro AM, Araœjo VA, Vella JP, Bossa AS, Biselli B, Leal TCAT, Soeiro MCFA, Serrano CV Jr, Mueller C, Oliveira Junior MT Is There Any Relationship between TSH Levels and Prognosis in Acute Coronary Syndrome? Arq Bras Cardiol. 2018. Impact Factor 1.318

76. Stamatelopoulos K, Mueller-Hennessen M, Georgiopoulos G, Sachse M, Boeddinghaus J, Sopova K, Gatsiou A, Amrhein C, Biener M, Vafaie M, Athanasouli F, Stakos D, Pateras K, Twerenbold R, Badertscher P, Nestelberger T, Dimmeler S, Katus HA, Zeiher AM, Mueller C, Giannitsis E, Stellos K. Amyloid-β (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study. Ann Intern Med. 2018. Impact Factor 19.384

77. Steinmann E, Brunner-La Rocca HP, Maeder MT, Kaufmann BA, Pfisterer M, Rickenbacher P. Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction? Eur J Intern Med. 2018. Impact Factor 3.282

78. Sticherling C, Arendacka B, Svendsen J, Wijers S, Friede T, Stockinger J, Dommasch M, Merkely B, Willems R, Lubinski A, Scharfe M, Braunschweig F, Svetoslak M, Zuern CS Huikuri H, Flevari, P, Lund-Andersen C, Schaer BA, Tuinenburg AE, Bergau L, Schmidt G, Szeplaki G, Vandenberk B, Kowalczyk, E, Eick C, Juntilla J, Conen D, Zabel M. Sex differences in outcomes of primary prevention implantable cardioverter defibrillator therapy: combined registry data from eleven European countries. Europace. 2018. Impact Factor 5.231

79. Sticherling C, MŸller D, Schaer BA, KrŸger S, Kolb C; Pre-CRAFT investigators Atrial electrogram quality in single-pass defibrillator leads with floating atrial bipole in patients with permanent atrial fibrillation and cardiac resynchronization therapy. Indian Pacing Electrophysiol 2018. Impact Factor 0.217

80. Stortecky S, Franzone A, Heg D, Tueller D, Noble S, Pilgrim T, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, GrŸnenfelder J, Muller O, Huber C, Roffi M, Carrel T, Wenaweser P, Windecker S. Temporal Trends in Adoption and Outcomes of Transcatheter Aortic Valve Implantation: A Swisstavi Registry Analysis. Eur Heart J Qual Care Clin Outcomes. 2018.

81. Strebel I, Twerenbold R, Boeddinghaus J, AbŠcherli R, Rubini Gim�nez M, Wildi K, Grimm K, Puelacher C, Badertscher P, Sabti Z, BreitenbŸcher D, Jann J, Selman F, du Fay de Lavallaz J, Schaerli N, Nestelberger T, Stelzig C, Freese M, Schumacher L, Osswald S, Mueller C, Reichlin T. Diagnostic value of the cardiac electrical biomarker, a novel ECG marker indicating myocardial injury, in patients with symptoms suggestive of non-ST-elevation myocardial infarction. Ann Noninvasive Electrocardiol. 2018. Impact Factor 1.562

82. Strebel I, Twerenbold R, Wussler D, Boeddinghaus J, Nestelberger T, du Fay de Lavallaz J, AbŠcherli R, Maechler P, Mannhart D, Kozhuha-rov N, Rubini Gim�nez M, Wildi K, Sazgary L, Sabti Z, Puelacher C, Badertscher P, Keller DI, Mir— ñ, Fuenzalida C, Calder—n S, Martin-Sanchez FJ, Iglesias SL, Osswald S, Mueller C, Reichlin T. Incremental diagnostic and prognostic value of the QRS-T angle, a 12-lead ECG marker quantifying heterogeneity of depolarization and repolarization, in patients with suspected non-ST-elevation myocardial infarction. Int J Cardiol. 2018. Impact Factor 4.034

51

83. Sticherling C, Arendacka B, Svendsen JH, Wijers S, Friede T, Stockinger J, Dommasch M, Merkely B, Willems R, Lubinski A, Scharfe M, Braunschweig F, Svetlosak M, ZŸrn CS, Huikuri H, Flevari P, Lund-Andersen C, Schaer BA, Tuinenburg AE, Bergau L, Schmidt G, Szeplaki G, Vandenberk B, Kowalczyk E, Eick C, Juntilla J, Conen D, Zabel M; EU-CERT-ICD Investigators. Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries. Europace. 2018. Impact Factor 5.231

84. Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Jobs A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Hunziker L, Savonitto S, Torremante P, Vrints C, Schneider S, Zeymer U, Desch S; CULPRIT-SHOCK Investigators. One-Year Outcomes after PCI Strategies in Cardiogenic Shock. N Engl J Med. 2018. Impact Factor 79.258

85. Tigges E, Blankenberg S, von Bardeleben RS, ZŸrn C, Bekeredjian R, Ouarrak T, Sievert H, Nickenig G, Boekstegers P, Senges J, Schillinger W, Lubos E. Implication of pulmonary hypertension in patients undergoing MitraClip therapy: results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail. 2018. Impact Factor 10.683

86. Trendelenburg M, Stallone F, Pershyna K, Eisenhut T, Twerenbold R, Wildi K, Dubler D,Schirmbeck L, Puelacher C, Rubini Gimenez M, Sabti Z, Osswald L, Breidthardt T, Mueller C. Complement activation products in acute heart failure: Potential role in pathophysiology, responses to treatment and impacts on long-term survival. Eur Heart J Acute Cardiovasc Care. 2018. Impact Factor 2.6

87. Twerenbold R, Badertscher P, Boeddinghaus J, Nestelberger T, Wildi K, Puelacher C, Sabti Z, Rubini Gim�nez M, Tschirky S, du Fay de Lavallaz J, Kozhuharov N, Sazgary L, Mueller D, Breidthardt T, Strebel I, Flores Widmer D, Shrestha S, Mir— ñ, Mart’n-S‡nchez FJ, Morawiec B, Parenica J, Geigy N, Keller DI, Rentsch K, von Eckardstein A, Osswald S, Reichlin T, Mueller C. 0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction. Circulation. 2018. Impact Factor 18.88

88. Twerenbold R, Neumann JT, Sšrensen NA, Ojeda F, Karakas M, Boeddinghaus J, Nestelberger T, Badertscher P, Rubini Gim�nez M, Puela-cher C, Wildi K, Kozhuharov N, Breitenbuecher D, Biskup E, du Fay de Lavallaz J, Flores D, Wussler D, Mir— ñ, Mart’n S‡nchez FJ, Morawiec B, Parenica J, Geigy N, Keller DI, Zeller T, Reichlin T, Blankenberg S, Westermann D, Mueller C. Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction. J Am Coll Cardiol. 2018. Impact Factor 16.834

89. van der Linden N, Wildi K, Twerenbold R, Pickering JW, Than M, Cullen L, Greenslade J, Parsonage W, Nestelberger T, Boeddinghaus J, Badertscher P, Rubini Gim�nez M, Klinkenberg LJJ, Bekers O, Schšni A, Keller DI, Sabti Z, Puelacher C, Cupa J, Schumacher L, Kozhuharov N, Grimm K, Shrestha S, Flores D, Freese M, Stelzig C, Strebel I, Mir— ñ, Rentsch K, Morawiec B, Kawecki D, Kloos W, Lohrmann J, Richards AM, Troughton R, Pemberton C, Osswald S, van Dieijen-Visser MP, Mingels AM, Reichlin T, Meex SJR, Mueller C. Combining High Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction. Circulation. 2018. Impact Factor 18.88

90. van der Stouwe JG, Carmeli C, Aeschbacher S, Schoen T, Krisai P, Wenger G, Ehret G, Ponte B, Pruijm M, Ackermann D, Guessous I, Pac-caud F, Pech�re-Bertschi A, Vogt B, Mohaupt MG, Martin PY, Burnier M, Risch M, Risch L, Bochud M, Conen D. Association of 24-hour blood pressure with urinary sodium excretion in healthy adults. Am J Hypertens. 2018. Impact Factor 4.092

91. Walter JE, Honegger U, Puelacher C, Mueller D, Wagener M, Schaerli N, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Sazgary L, Marbot S, de Lavallaz JDF, Kaiser C, Osswald S, Wild D, Rentsch K, Zellweger M, Reichlin T, Mueller C. Prospective Validation of a Biomarker-Based Rule Out Strategy for Functionally Relevant Coronary Artery Disease. Clin Chem. 2018. Impact Factor 8.636

92. Whitehead N, Gill JF, Brink M and Handschin C. Moderate modulation of cardiac PGC-1alpha expression partially affects age-associated transcriptional remodeling of the heart. Frontiers in physiology. 2018. Impact Factor 2.089

93. Wildi K, Boeddinghaus J, Nestelberger T, Twerenbold R, Badertscher P, Wussler D, Gim�nez MR, Puelacher C, du Fay de Lavallaz J, Dietsche S, Walter J, Kozhuharov N, Morawiec B, Mir— ñ, Javier Martin-Sanchez F, Subramaniam S, Geigy N, Keller DI, Reichlin T, Mueller C; APACE investigators. Comparison of fourteen rule-out strategies for acute myocardial infarction. Int J Cardiol. 2018. Impact Factor 4.034

Publikationen

10 Publikationen

52

94. Wildi K, Singeisen H, Twerenbold R, Badertscher P, Wussler D, Klinkenberg LJJ, Meex SJR, Nestelberger T, Boeddinghaus J, Mir— ñ, Martin-Sanchez FJ, Morawiec B, Muzyk P, Parenica J, Keller DI, Geigy N, Potlukova E, Sabti Z, Kozhuharov N, Puelacher C, du Fay de Lavallaz J, Rubini Gimenez M, Shrestha S, Marzano G, Rentsch K, Osswald S, Reichlin T, Mueller C; APACE Investigators. Circadian rhythm of cardiac troponin I and its clinical impact on the diagnostic accuracy for acute myocardial infarction. Int J Cardiol. 2018. Impact Factor 4.034

95. Wuest S, Twerenbold R, KŸhne M, Reichlin T, Sticherling C, Osswald S, Schaer B. Reassessment of cardiovascular parameter and comor-bidities in implantable cardoverter-defibrillator patients at the time of first replacement. Clin Cardiol. 2018. Impact Factor 2.733

96. Zabel M, Sticherling C, Rik Willems, Lubinski A, Bauer A, Bergau L, Braunschweig F, Brugada J, Brusich S, Conen D, Cygankiewicz I, Flevari P, Taborsky M, Hansen J, Hasenfuß G, Hatala R, Huikuri HV, KŠŠb S, Kaliska G, Kasprzak JD, LŸthje L, Malik M, Novotn� T, Pavlovic N, Schmidt G, Shalganov T, Sritharan R, Schlšgl SC, Szavits-Nossan J, Traykov V, Tuinenburg A, Velchev V, Vos MA, Willich SN, Friede T, Hastrup Svendsen J, Merkely B, for the EU-CERT-ICD Study Investigators. Rationale, Objectives and Design of the EU-CERT-ICD (Comparative Effec-tiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) Prospective Study: Use of an Observational Controlled Study Design to Assess the Comparative Effectiveness of Primary Prophylactic ICD Implantation. ESC Heart Fail J. 2018. Impact Factor 10.683

97. Zeljkovic I, Burri H, Breitenstein A, Ammann P, Mueller A, Auricchio A, Delacr�taz E, Dickstein K, Linde C, Normand C, Sticherling C. Cardiac Resynchronisation Therapy (CRT) Survey II: CRT implantation in Europe in Switzerland, Swiss Med Wkly. 2018. Impact Factor 1.928

98. Zellweger MJ, Tsirkin A, Vasilchenko V, Failer M, Dressel A, Kleber ME, Ruff P, MŠrz W. A new non-invasive diagnostic tool in coronary artery disease: artificial intelligence as an essential element of predictive, preventive, and personalized medicine. EPMA J. 2018. Impact Factor 3.900

Reviews

1. Berger S, Meyre P, Blum S, Aeschbacher S, Ruegg M, Briel M, Conen D. Bariatric surgery among patients with heart failure: a systematic review and meta-analysis. Open Heart. 2018.

2. Blum S, Meyre P, Aeschbacher S, Berger S, Auberson C, Briel M, Osswald S, Conen D. Incidence and predictors of atrial fibrillation progres-sion: A systematic review and meta-analysis. Heart Rhythm. 2018. Impact Factor 4.743

3. Boehm K, Duckheim M, Mizera L, Groga-Bada P, Malek N, Kreth F, Gawaz M, Zuern CS, Eick C. Heart rate variability for rapid risk stratifica-tion of emergency patients with malignant disease. Support Care Cancer. 2018. Impact Factor 2.676

4. Boriani G, Merino J, Wright DJ, Gadler F, Schaer B, Landolina M. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA. Europace. 2018. Impact Factor 5.231

5. Boriani G, Fauchier L, Aguinaga L, Beattie JM, Blomstrom Lundqvist C, Cohen A, Dan GA, Genovesi S, Israel C, Joung B, Kalarus Z, Lampert R, Malavasi VL, Mansourati J, Mont L, Potpara T, Thornton A, Lip GYH, Goronek B, Marin F, Dagres N, Ozcan EE, Lenarczyk R, Crijns HJ, Guo Y, Proietti M, Sticherling C, Huang D, Dauber JP, Pokorney SD, Ortega MC, Chin A. European Heart RhythmAssociation (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart RhythmSociety (HRS), Asia Pacific Heart RhythmSociety

6. Ebner M, Birschmann I, Peter A, HŠrtig F, Spencer C, Kuhn J, Rupp A, Blumenstock G, Zuern CS, Ziemann U, Poli S. Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis. J Am Heart Assoc. 2018 Oct 2. Impact Factor 4.45

7. Eick C, Groga-Bada P, Reinhardt K, Duckheim M, Mizera L, Bšhm K, Gštz N, Gawaz M, ZŸrn C. Nocturnal respiratory rate as a predictor of mortality in patients with acute coronary syndrome. Open Heart. 2018.

53

8. Geis NA, Puls M, Lubos E, Zuern CS, Franke J, Schueler R, von Bardeleben RS, Boekstegers P, Ouarrak T, Zahn R, Ince H, Senges J, Katus HA, Bekeredjian R. Safety and efficacy of MitraClipª therapy in patients with severely impaired left ventricular ejection fraction: results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail. 2018. Impact Factor 10.683

9. Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, Crespo-Leiro MG, Guazzi M, Harjola VP, Heymans S, Hill L, Lainscak M, Lam CSP, Lund LH, Lyon AR, Mebazaa A, Mueller C, Paulus WJ, Pieske B, Piepoli MF, Ruschitzka F, Rutten FH, Seferovic PM, Solomon SD, Shah SJ, Triposkiadis F, Wachter R, Tschšpe C, de Boer RA. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018. Impact Factor 10.683

10. (APHRS),Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart RhythmSociety (LAHRS). Europace. 2018.Impact Factor 5.231

11. Harjola VP, Parissis J, Brunner-La Rocca HP, Celutkien� J, Chioncel O, Collins SP, De Backer D, Filippatos GS, Gayat E, Hill L, Lainscak M, Lassus J, Masip J, Mebazaa A, Mir— ñ, Mortara A, Mueller C, Mullens W, Nieminen MS, Rudiger A, Ruschitzka F, Seferovic PM, Sionis A, Vieillard-Baron A, Weinstein JM, de Boer RA, Crespo-Leiro MG, Piepoli M, Riley JP. Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2018. Impact Factor 10.683

12. Hern‡ndez-Madrid A, Paul T, Abrams D, Aziz PF, Blom NA, Chen J, Chessa M, Combes N, Dagres N, Diller G, Ernst S, Giamberti A, Hebe J, Janousek J, Kriebel T, Moltedo J, Moreno J, Peinado R, Pison L, Rosenthal E, Skinner JR, Zeppenfeld K; Sticherling C, Kautzner J, Wissner E, Sommer P, Gupta D, Szili-Torok T, Tateno S, Alfaro A, Budts W, Gallego P, Schwerzmann M, Milanesi O, Sarquella-Brugada G, Kornyei L, Sreeram N, Drago F, Dubin A. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace. 2018. Impact Factor 5.231

13. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsk� P; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the ma-nagement of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018. Impact Factor 23.425

14. Jeger RV, Mšbius-Winkler S. Stents in saphenous vein grafts. Lancet. 2018. Impact Factor 53.254

15. Liu YC, Pfister O. How to diagnose heart failure? Ther Umsch. 2018.

16. Mair J, Lindahl B, Hammarsten O, Mueller C, Giannitsis E, Huber K, Mšckel M, Plebani M, Thygesen K, Jaffe AS. How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care. 2018. Impact Factor 2.6

17. Masip J, Peacock WF, Price S, Cullen L, Martin-Sanchez FJ, Seferovic P, Maisel AS, Miro O, Filippatos G, Vrints C, Christ M, Cowie M, Platz E, McMurray J, DiSomma S, Zeymer U, Bueno H, Gale CP, Lettino M, Tavares M, Ruschitzka F, Mebazaa A, Harjola VP, Mueller C. Indications and practical approach to non-invasive ventilation in acute heart failure. Eur Heart J. 2018. Impact Factor 23.425

18. McDonagh T, Damy T, Doehner W, Lam CSP, Sindone A, van der Meer P, Cohen-Solal A, Kindermann I, Manito N, Pfister O, PohjantŠhti-Maaroos H, Taylor J, Comin-Colet J. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur J Heart Fail. 2018. Impact Factor 10.683

19. Mizera L, Boehm K, Duckheim M, Groga-Bada P, Gawaz M, Zuern CS, Eick C. Autonomic Nervous System Activity for Risk Stratification of Emergency Patients With Pneumonia. J Emerg Med. 2018 Oct. Impact Factor 1.207

Publikationen

10 Publikationen

54

20. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, JŸni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadar R, Zembala MO; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019. Impact Factor 23.425

21. Sousa-Uva M, Neumann FJ, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, JŸni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Docu-ment Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2019. Impact Factor 3.504

22. Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Rubini Gimenez M, Badertscher P, Mueller C. How to best use high-sensitivity cardiac troponin in patients with suspected myocardial infarction. Clin Biochem. 2018. Impact Factor 2.584

23. Walker DM, Gale CP, Lip G, Martin-Sanchez FJ, McIntyre HF, Mueller C, Price S, Sanchis J, Vidan MT, Wilkinson C, Zeymer U, Bueno H. Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care. 2018. Impact Factor 2.6

24. Zuern CS, Floss N, Mueller II, Eick C, Duckheim M, Patzelt J, Gawaz M, May AE, Mueller KAL. Galectin-3 is associated with left ventricular reverse remodeling and outcome after percutaneous mitral valve repair. Int J Cardiol. 2018. Impact Factor 4.034

Case Reports, eingeladene Reviews & Editorials

1. Aeschbacher S, Conen D. Healthy lifestyle and prevention of atrial fibrillation: Weighty matters. Eur J Prev Cardiol. 2018. Impact Factor 4.542

2. Haaf P, Kadner A, Tabbara S, Kessel-Schaefer A. Cavopulmonary window: case report of an unusual variant of a sinus venosus defect. European Heart Journal. 2018. Impact Factor 23.425

3. Kilian L, Haaf P, Pfister O, Vischer AS, Lapaire O, Burkard T. Reverse Takotsubo syndrome, a case report of a rare cause for postpartum heart failure. Cardiogenetics.

4. Knecht S, Brantner P, Cattin P, Tobler D, KŸhne M, Sticherling C. State-of-the-art multi-modality approach to assist ablations in complex anatomies - from 3D printing to virtual reality. Pacing Clin Electrophysiol. 2018. Impact Factor 1.441

5. Kozhuharov N, Madaffari A, Schaer B, Sticherling C. Kardiale Resynchronisationstherapie. info@herz+gefŠss. 2018.

6. Kozhuharov N, Sticherling C, SchŠr B. Device-Therapie bei Herzinsuffizienz. Therapeutische Umschau. 2018.

7. KŸhne M. Kartografie des Herzens mittels Mappingsystemen. Praxis (Bern 1994). 2018.

8. Perrin T, KŸhne M, Novak J. Positional pseudo-alternating bundle-branch-block on implantable loop recorder electrogram. Indian Pacing Electrophysiol J. 2018.

9. Rickenbacher P. Herzinsuffizienz - ein Dauerbrenner in Praxis und Spital. Therapeutische Umschau. 2018.

10. Rickenbacher P. Herzinsuffizienz mit "mid-range" Auswurffraktion: eine neue klinische EntitŠt? Therapeutische Umschau. 2018.

11. Zeljkovic I, Knecht S, Madaffari A, Mannhart D, Burri S, Germann A, Sticherling C, KŸhne M. Dual tachycardia involving the cavotricuspid isthmus and Eustachian ridge. Cardiovasc Med. 2018. Impact Factor 1.67

12. Zeljkovic I, Knecht S, Sticherling C, KŸhne M. Wide and narrow QRS complex tachycardia with four different cycle lengths: What is the mechanism? Heart Rhythm. 2018. Impact Factor 4.743

13. Zellweger MJ. Despite some caveats: a normal myocardial perfusion result is still a strong value! Eur Heart J Cardiovasc Imaging. 2018.No abstract available. Impact Factor 23.425 55

Buchkapitel

Sticherling C, KŸhne M. Management of acute presentation with atrial fibrillation - rate control. In: Camm AJ, LŸscher TF, Maurer G, Serruys PW: ESC CardioMed (3 ed.). 2018.

Pfister O. Anemia and iron deficiency in heart failure. Heart Failure Text book, edited by Feldmann DS and Mohacsi P. Springer 171-178 (in press)

Letter to the editor

1. Dietsche SL, Breidthardt T, Kozhuharov N, Mueller C. Heart Failure: It Is Not Just Yes or No. J Am Coll Cardiol. 2018. Impact Factor 16.834

2. Gualandro DM, Caramelli B, Puelacher C, Mueller C. Reply. Cardiac troponin in vascular surgery. J Vasc Surg. 2018. Impact Factor 3.294

3. Kaier TE, Twerenbold R, Puelacher C, Marjot J, Imambaccus N, Boeddinghaus J, Nestelberger T, Badertscher P, Sabti Z, Rubini Gim�nez M, Wildi K, Hillinger P, Grimm K, Loeffel S, Shrestha S, Flores Widmer D, Cupa J, Kozhuharov N, Mir— ñ, Martín-S‡nchez FJ, Morawiec B, Rentsch K, Lohrmann J, Kloos W, Osswald S, Reichlin T, Weber E, Marber M, Mueller C. Response by Kaier et al to Letter Regarding Article, Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction. Circulation. 2018. Impact Factor 18.88

4. Morello F, Mueller C, Soeiro AM, Leidel BA, Salvadeo SAT, Nazerian P; ADvISED Investigators. Response by Morello et al to Letters Re-garding Article, "Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D-Dimer for Acute Aortic Syndroms: The ADvISED Prospective Multicenter Study". Circulation. 2018. Impact Factor 18.88

5. Nestelberger T, Boeddinghaus J, Badertscher P, Twerenbold R, Mueller C. Reply: Clarifying the Proper Definitions for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2018. Impact Factor 16.834

6. Nestelberger T, Boeddinghaus J, Mueller C. Letter by Nestelberger et al Regarding Article, Association Between Early Hyperoxia Exposure After Resuscitation from Cardiac Arrest and Neurological Disability: Prospective Multicenter Protocol-Directed Cohort Study. Circulation. 2018. Impact Factor 18.88

7. Nestelberger T, Boeddinghaus J, Mueller C. Type 2 myocardial infarction. Eur Heart J. 2018. Impact Factor 23.425

8. Nestelberger T, Boeddinghaus J, Badertscher P, Twerenbold R, Mueller C. Reply: Clarifying the Proper Definitions for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2018. Impact Factor 16.834

9. Puelacher C, Mueller C. Response by Puelacher and Mueller to Letters Regarding Article, Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization. Circulation. 2018. Impact Factor 18.88

10. Twerenbold R, Neumann JT, Blankenberg S, Westermann D, Mueller C. Reply: Hospital Charges Associated With Inpatient Troponin Testing. J Am Coll Cardiol. 2018. Impact Factor 16.834

11. Wein B, Kaiser C. Prasugrel vs clopidogrel in contemporary Western European patients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohorts - Response to the letter to the Editor. Int J Cardiol. 2018. Impact Factor 4.034

12. Wussler D, du Fay de Lavallaz J, Mueller C. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke. N Engl J Med. 2018. Impact Factor 79.258

13. Wussler D, Walter J, du Fay de Lavallaz J, Strebel I, Mueller C. Time to Diuretic in Acute Heart Failure. JACC Heart Fail. 2018. Impact Factor 8.202

Auszeichnungen

Auszeichnungen

Dr. Raphael Twerenbold (Preis der Schweiz. Herzstiftung)

Dr. Christian Puelacher (Preis der Schweizerischen Gesellschaft fŸr Kardiologie)

Dr. Patrick Badertscher (Preis der Schweizerischen Gesellschaft fŸr Kardiologie)

Dr. Jasper Boeddinghaus (Preis der Schweizerischen Gesellschaft fŸr Kardiologie)

Dr. Jeanne du Fay de Lavallaz (GREAT Research Award)

Dissertationen

Dissertationen bei Prof. Roland Bingisser

Dr. Bosia Tito: Risk of adverse outcome in patients referred by emergency medical services in Switzerland

Dr. Dietrich Marc: Systematically assessed symptoms as out-come predictors in emergency patients

Dr. Weigel Karin Dorothee: DoctorSymptoms at presentation to the emergency department: Predicting outcomes and changing clinical practice?

Dissertationen bei Prof. David Conen

Dr. Bernasconi Raffaele: Fibroblast growth factor 23 and renal function among young and healthy individuals

Dr. Eggimann Lucien Ren�: Risk factors for heart failure hospi-talizations among patients with atrial fibrillation

Dr. Egli Peter: Relationships of kidney injury molecule-1 with renal function and cardiovascular risk factors in the general population

Dr. Reusser Andreas Thierry: QTc interval, cardiovascular events and mortality in patients with atrial fibrillation

11 Auszeichnungen

Dissertation bei Prof. Martin Grapow

Dr. Kunz Donatina Regina: Rapamycin impairs endothelial cell function in human internal thoracic arteries by downregulati-on of the protein kinase B

Dissertation bei Prof. Michael KŸhne

Dr. Burch Fabian: First clinical experience of a dedicated irri-gated-tip radiofrequency ablation catheter for the ablation of cavotricuspid isthmus-dependent atrial flutter

Dissertationen bei Prof. Christian MŸller

Dr. Aeppli Sven: How Accurate is Clinical Assessment of Neck Veins in the Estimation of Central Venous Pressure in Acute Heart Failure? Insights from a Prospective Study

Dr. Bergsma Patrick Peter: Natural History of Syncope

Dr. BreitenbŸcher Dominik Nicolas: Validation of the European Society of Cardiology 0/1-Hour Algorithm for Rapid Rule-out and Rule-in of Acute Myocardial Infarction

Dr. Cupa Janosch: "Diagnostic and prognostic value of QRS duration and QTc interval in patients with suspected myocar-dial infarction"

Dr. Dietsche Sebastian: Comparison of fourteen rule-out stra-tegies for acute myocardial infarction

Dr. Flores Dayana Alejandra: "Circadian, Weekly, Seasonal and Temperature-Dependent Patterns of Syncope Etiology"

Dr. Gantenbein Claudine: Impact of Haemoconcentration du-ring Acute Heart Failure Therapy on Mortality and its Relation-ship with Worsening Renal Function

Dr. Herrmann Thomas GŸnther: Proenkephalin, prediction of renal dysfunction and short and longer term prognosis in acu-te heart failure - a GREAT network study

56

Dr. Isenrich Rahel Anna: Prospective Validation of Prognostic and Diagnostic Syncope Scores in the Emergency Department

Dr. Loeffel Sarah: Direct comparison of cardiac myosin-bin-ding protein C to cardiac troponins for the early diagnosis of acute myocardial infarction

Dr. Meili Yvette: Use of Copeptin for the Early Diagnosis of Acute Myocardial Infarction in Patients with Mild Elevations in Cardiac Troponin

Dr. MŸller Deborah Mirjam: Direct Comparison of Cardiac Troponin T and I Using a Uniform and a Sex-Specific Ap-proach in the Detection of Functionally Relevant Coronary Artery Disease

Dr. PfŠffli Julian: Effects of pre-test probability on diagnostic and prognostic performance of high-sensitivity cardiac tropo-nin for acute myocardial infarction

Dr. Puelacher Christian, PhD-thesis "Perioperative Myocardial Injury in Non-cardiac Surgery - Incidence, Patient Characteris-tics, Outcome, and Possible Strategies to Improve Outcome" Summa cum laude

Dr. Reidt Saskia Samira: Validation of NICE diagnostic guidance for rule out of myocardial infarction using high-sensitivity troponin tests

Dr. Schneider Deborah Elizabeth: Impact of the Definition on Incidence and Prognosis of Type 2 Myocardial Infarction

Dr. Seeberger Daniela Gabriela: Perioperative myocardial in-jury after non-cardiac surgery: incidence, mortality, and cha-racterization

Dr. Tschuck Michael Thomas: Pro-hormones in the Early Dia-gnosis of Cardiac Syncope

Dr. Vogt Fabian: Direct Comparison of B-type Natriuretic Pep-tide and N-terminal Pro-B-type Natriuretic Peptide in Patients with Acute Dyspnea

Dissertation bei Prof. Peter Rickenbacher

Dr. Steinmann Eva Stefanie: Is the clinical presentation of chro-nic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?

Dissertationen bei Prof. Beat SchŠr

Dr. Altermatt Benedikt Jonathan: Publication rate and impact factor of abstracts presented at SSC congresses 2011 to 2014

Dr. WŸst Sandra: Reassessment of cardiovascular parameters and comorbidities in implantable cardioverter-defibrillator pa-tients at the time of first replacement

Dr. von Gunten Simon Tobias:“Longevity of implantable cardi-overter defibrillators: a comparison among manufacturers and over time“

Dissertation bei Prof. Michael Zellweger

Dr. Caobelli Federico: Prognostic Usefulness of Cardiac Stress Test Modalities in Patients With Type 2 Diabetes Mellitus Who Underwent Myocardial Perfusion Scintigraphy (from the Basel Asymptomatic High-Risk Diabetics’ Outcome Trial)

PhD Dissertation bei PD Dr. Gabriela M. Kuster

Dr. Giacomo Della Verde: Role of fms-like tyrosine kinase 3 in cardiac health and disease. (Magna cum laude)

Forschungspreis

Dr. Sebastian Staubli - Dirk SchŠfer Wissenschaftspreis to for the publication: Control of angiogenesis and host response by modulating the cell adhesion properties of an Elastin-Like Re-combinamer-based hydrogel. Staubli SM, Cerino G, Gonzalez De Torre I, Alonso M, Oertli D, Eckstein F, Glatz K, Rodr’guez Cabello JC, Marsano A. Biomaterials. 2017.

57

Kontakt

Kardiologie Basel

ChefarztProf. Dr. med. Stefan Osswald

AnschriftKardiologie BaselUniversitŠtsspital BaselPetersgraben 4CH - 4031 Baselunispital-basel.ch/kardiologie

Allgemeine AuskŸnfteTel +41 61 265 44 44, Fax +41 61 265 45 98Email: [email protected]

Anmeldung ambulante und stationŠre Patienten Tel. +41 61 265 44 45, Fax +41 61 265 55 75Email: [email protected]

Anmeldung kardiale RehabilitationTel. +41 61 328 65 27, Fax +41 61 265 55 03Email: [email protected]

Dienstarzt KardiologieTel. + 41 61 556 58 00

12 Kontakt

Herzchirurgie Basel

ChefarztProf. Dr. med. Friedrich Eckstein

AnschriftHerzchirurgie BaselUniversitŠtsspital BaselSpitalstrasse 21CH - 4031 Baselunispital-basel.ch/herzchirurgie

ChefarztsekretariatJolanda Giess Tel. +41 61 265 71 45, Fax +41 61 265 73 24Email: [email protected]

AnmeldungStationŠre Patienten Tel. + 41 61 265 71 45Ambulante Patienten Tel. + 41 61 265 71 45Aortensprechstunde Tel. + 41 61 265 71 46

Dienstarzt HerzchirurgieTel. + 41 61 556 58 58

58

Impressum

Herausgeber: Herzzentrum Basel; Redaktion: Christoph Kaiser (Leitung), Stefan Osswald, Friedrich Eckstein, Christian MŸller, Arton Jusaj, Markus Riesterer; Fotos: Patrick Sayer, Markus Riesterer, Fabian Fiechter, Foto & Print Center USB, Christian Jaeggi; Konzeption: Markus Riesterer; Gestaltung: strawberry design; Druck: strawberry events; Auflage: 1'800 Ex.

Diese Publikation, einschliesslich all ihrer Texte, ist urheberrechtlich geschŸtzt. Jede Verwendung ausserhalb der engen Grenzen des Urheberrechts ist ohne Zustimmung des Herzzentrums und der beteiligten Institutionen unzulŠssig und strafbar. Dies gilt insbesondere fŸr VervielfŠltigungen, †bersetzungen, Mikroverfilmungen, sowie fŸr die Einspeicherung und Verarbeitung in elektronischen Systemen.

unispital-basel.ch/kardiologie I unispital-basel.ch/herzchirurgie

Documents

Herzzentrum - unispital-basel.ch · der Kardiologie des USB hat sich hier zum Beispiel das Konzept der interdisziplinŠren systematischen Mortality und Morbidity (M&M) Konferenz etabliert